UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September 30, 2019~~March 31, 2020

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission File Number: 0-21810

GENTHERM INCORPORATED

(Exact name of registrant as specified in its charter)

Michigan		95-4318554
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
21680 Haggerty Road, Northville, MI		48167
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (248) 504-0500

Securities registered pursuant to Section ~~12-(b)~~12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, no par value	THRM	~~NASDAQ~~Nasdaq

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

At ~~October 25, 2019,~~May 4, 2020, there were ~~32,659,545~~32,599,412 issued and outstanding shares of Common Stock of the registrant.

GENTHERM INCORPORATED

TABLE OF CONTENTS



Part I. Financial Information			3
	Item 1.	Financial Statements (Unaudited)	3
		Consolidated Condensed Balance Sheets	3
		Consolidated Condensed Statements of Income ~~(Loss)~~	4
		Consolidated Condensed Statements of Comprehensive (Loss) Income ~~(Loss)~~	5
		Consolidated Condensed Statements of Cash Flows	6
		Consolidated Condensed Statements of Changes in Shareholders’ Equity	7
		Notes to Unaudited Consolidated Condensed Financial Statements	98
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2724
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3536
	Item 4.	Controls and Procedures	3637
Part II. Other Information			3738
	Item 1.	Legal Proceedings	3738
	Item 1A.	Risk Factors	3738
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3740
	Item 6.	Exhibits	3841
Signatures			3942

PART I. FINANCIAL INFORMATION

ITEM 1.

FINANCIAL STATEMENTS

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

	September 30, 2019			December 31, 2018			March 31, 2020			December 31, 2019
ASSETS
Current Assets:
Cash and cash equivalents	$	45,200		$	39,620		$	222,939		$	50,443
Restricted cash		2,504			—			2,505			2,505
Accounts receivable, less allowance of $1,040 and $851, respectively		170,823			166,858
Accounts receivable, less allowance of $1,639 and $1,193, respectively								159,011			159,710
Inventory:
Raw materials		65,337			61,679			60,844			61,323
Work in process		6,863			5,939			6,778			7,444
Finished goods		46,591			44,917			50,019			49,712
Inventory, net		118,791			112,535			117,641			118,479
Derivative financial instruments		897			92
Prepaid expenses and other assets		39,884			54,271
Assets held for sale		6,742			69,699
Other current assets								44,941			42,726
Total current assets		384,841			443,075			547,037			373,863
Property and equipment, net		162,783			171,380			152,120			160,605
Goodwill		63,501			55,311			63,894			64,572
Other intangible assets, net		51,338			56,385			50,062			49,783
Operating lease right-of-use assets		12,136			—			14,991			11,587
Deferred financing costs		1,692			647
Deferred income tax assets		54,380			64,024			56,032			57,650
Other non-current assets		7,000			12,225			9,234			9,326
Total assets	$	737,671		$	803,047		$	893,370		$	727,386
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	89,293		$	93,113		$	97,065		$	83,035
Accrued liabilities		67,482			65,808
Current lease liabilities		4,483			—			4,735			4,586
Current maturities of long-term debt		2,500			3,413			2,500			2,500
Liabilities held for sale		6,742			13,062
Other current liabilities								67,000			66,583
Total current liabilities		170,500			175,396			171,300			156,704
Long-term debt, less current maturities								231,667			78,124
Pension benefit obligation		6,596			7,211			7,619			8,057
Non-current lease liabilities		7,391			—			10,869			6,751
Long-term debt, less current maturities		97,123			136,477
Deferred income tax liabilities		1,142			1,177
Other non-current liabilities		3,326			3,087			1,534			5,100
Total liabilities	$	286,078		$	323,348		$	422,989		$	254,736
Shareholders’ equity:
Common Stock:
No par value; 55,000,000 shares authorized, 32,741,826 and 33,856,629 issued and outstanding at September 30, 2019 and December 31, 2018, respectively		103,781			140,300
No par value; 55,000,000 shares authorized, 32,598,854 and 32,674,354 issued and outstanding at March 31, 2020 and December 31, 2019, respectively								102,059			102,507
Paid-in capital		11,348			14,934			9,648			10,852
Accumulated other comprehensive loss		(54,814	)		(39,500	)		(54,931	)		(42,441	)
Accumulated earnings		391,278			363,965			413,605			401,732
Total shareholders’ equity		451,593			479,699			470,381			472,650
Total liabilities and shareholders’ equity	$	737,671		$	803,047		$	893,370		$	727,386

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF INCOME ~~(LOSS)~~

(In thousands, except per share data)

(Unaudited)

													Three Months Ended
	Three Months Ended September 30,						Nine Months Ended September 30,						March 31,
	2019			2018			2019			2018			2020			2019
Product revenues	$	240,056		$	261,504		$	741,303		$	792,490		$	228,613		$	257,921
Cost of sales		165,364			185,800			518,590			558,452			162,546			182,614
Gross margin		74,692			75,704			222,713			234,038			66,067			75,307
Operating expenses:
Net research and development expenses		18,838			19,056			56,990			63,382			17,760			18,897
Selling, general and administrative expenses		26,861			35,117			91,683			105,803			25,840			32,651
Restructuring expenses		8,664			5,818			11,809			12,898			3,766			1,914
Total operating expenses		54,363			59,991			160,482			182,083			47,366			53,462
Operating income		20,329			15,713			62,231			51,955			18,701			21,845
Interest expense		(1,148	)		(1,241	)		(3,756	)		(3,661	)
Foreign currency gain		4,083			125			3,482			721
Interest expense, net														(748	)		(1,368	)
Foreign currency (loss) gain														(938	)		203
Gain on sale of business		—			—			4,970			—			—			4,970
Impairment loss		(837	)		(11,476	)		(21,206	)		(11,476	)		—			(10,484	)
Other income		231			212			545			1,538			264			143
Earnings before income tax		22,658			3,333			46,266			39,077			17,279			15,309
Income tax expense		6,771			3,688			19,214			9,807			5,406			6,895
Net income (loss)	$	15,887		$	(355	)	$	27,052		$	29,270
Basic earnings (loss) per share	$	0.48		$	(0.01	)	$	0.81		$	0.80
Diluted earnings (loss) per share	$	0.48		$	(0.01	)	$	0.81		$	0.80
Net income													$	11,873		$	8,414
Basic earnings per share													$	0.36		$	0.25
Diluted earnings per share													$	0.36		$	0.25
Weighted average number of shares – basic		32,839			36,104			33,283			36,364			32,693			33,573
Weighted average number of shares – diluted		32,933			36,448			33,419			36,470			32,869			33,733

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME ~~(LOSS)~~

(In thousands)

(Unaudited)

Three Months Ended
September 30,

Nine Months Ended
September 30,

2019

2018

2019

2018

Net income (loss)

$
15,887

$
(355
)

$
27,052

$
29,270

Other comprehensive income (loss), gross of tax:

Foreign currency translation adjustments loss

(14,857
)

(3,266
)

(15,454
)

(14,519
)
Unrealized (loss) gain on foreign currency derivative securities

(257
)

1,753

806

2,304

Unrealized loss on commodity derivative securities

—

—

—

(218
)
Other comprehensive loss, gross of tax

$
(15,114
)

$
(1,513
)

$
(14,648
)

$
(12,433
)
Other comprehensive income (loss), related tax effect:

Cumulative effect of accounting change due to ASU 2018-02

—

—

—

(40
)
Foreign currency translation adjustments loss

(315
)

15

(489
)

(217
)
Unrealized (loss) gain on foreign currency derivative securities

55

(536
)

(177
)

(684
)
Unrealized loss on commodity derivative securities

—

—

—

(59
)
Other comprehensive loss, related tax effect

$
(260
)

$
(521
)

$
(666
)

$
(1,000
)
Other comprehensive loss, net of tax

$
(15,374
)

$
(2,034
)

$
(15,314
)

$
(13,433
)
Comprehensive income (loss)

$
513

$
(2,389
)

$
11,738

$
15,837

	Three Months Ended
	March 31,
	2020			2019
Net income	$	11,873		$	8,414
Other comprehensive (loss) income:
Foreign currency translation adjustments		(8,740	)		(4,251	)
Unrealized (loss) gain on foreign currency derivative securities, net of tax		(3,750	)		599
Other comprehensive loss, net of tax		(12,490	)		(3,652	)
Comprehensive (loss) income	$	(617	)	$	4,762

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Nine Months Ended September 30,						Three Months Ended March 31,
	2019			2018			2020			2019
Operating Activities:
Net income	$	27,052		$	29,270		$	11,873		$	8,414
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		33,281			38,721			10,406			11,052
Deferred income taxes		5,072			(19	)		721			1,749
Stock compensation		5,268			6,360
Defined benefit plan income		(754	)		(219	)
Provision of doubtful accounts		209			247
Stock based compensation								1,942			1,968
Defined benefit plan expense (income)								85			(617	)
Allowance for credit losses								451			229
Loss on sale of property and equipment		319			2,273			119			178
Operating lease expense		4,477			—			1,651			1,333
Impairment loss		21,206			11,476			—			10,484
Gain on sale of business		(4,970	)		—			—			(4,970	)
Other		189			—
Changes in assets and liabilities:
Accounts receivable		(6,170	)		(13,855	)		(2,491	)		(8,293	)
Inventory		(5,512	)		(3,510	)		(404	)		(229	)
Prepaid expenses and other assets		9,594			(7,867	)
Other assets								(4,805	)		(5,553	)
Accounts payable		(3,097	)		8,376			13,540			(2,079	)
Accrued liabilities		(2,172	)		(712	)
Other liabilities								(3,669	)		(6,785	)
Net cash provided by operating activities		83,992			70,541			29,419			6,881
Investing Activities:
Proceeds from the sale of property and equipment		137			703			34			28
Proceeds from sale of a business		47,500			—
Acquisition of subsidiary, net of cash acquired		(14,823	)		(15	)
Proceeds from divestiture of business								—			47,500
Acquisition of intangible assets								(3,141	)		—
Purchases of property and equipment		(18,340	)		(31,815	)		(3,231	)		(5,150	)
Net cash provided by (used in) investing activities		14,474			(31,127	)
Net cash (used in) provided by investing activities								(6,338	)		42,378
Financing Activities:
Borrowing of debt		29,470			18,000			169,546			10,428
Repayments of debt		(69,049	)		(61,210	)		(16,111	)		(49,627	)
Cash paid for financing costs		(1,278	)		—
Cash paid for the cancellation of restricted stock		(1,213	)		(882	)		(404	)		(376	)
Proceeds from the exercise of Common Stock options		13,879			14,062			5,902			214
Repurchase of Common Stock		(58,040	)		(64,151	)
Net cash used in financing activities		(86,231	)		(94,181	)
Cash paid for the repurchase of Common Stock								(9,092	)		(8,040	)
Net cash provided by (used in) financing activities								149,841			(47,401	)
Foreign currency effect		(4,151	)		(1,253	)		(426	)		(209	)
Net increase (decrease) in cash, cash equivalents and restricted cash		8,084			(56,020	)
Net increase in cash, cash equivalents and restricted cash								172,496			1,649
Cash, cash equivalents and restricted cash at beginning of period		39,620			103,172			52,948			39,620
Cash, cash equivalents and restricted cash at end of period	$	47,704		$	47,152		$	225,444		$	41,269
Supplemental disclosure of cash flow information:
Cash paid for taxes	$	6,676		$	19,255		$	3,525		$	3,466
Cash paid for interest	$	3,437		$	3,617		$	537		$	1,252
Supplemental disclosure of non-cash transactions:
Common Stock issued to Board of Directors and employees	$	4,576		$	3,893

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(In thousands)

(Unaudited)

Accumulated

Other

Common Stock

Paid-in

Comprehensive

Accumulated

Shares

Amount

Capital

Income (Loss)

Earnings

Total

Balance at December 31, 2018

33,857

$
140,300

$
14,934

$
(39,500
)
$
363,965

$
479,699

Cumulative effect of accounting change due to
   adoption of ASU 2016-02

—

—

—

—

261

261

Stock repurchase

(200
)

(8,040
)

—

—

—

(8,040
)
Exercise of Common Stock options for cash

13

1,021

(807
)

—

—

214

Cancellation of restricted stock

(17
)

(376
)

—

—

—

(376
)
Stock option compensation

—

—

386

—

—

386

Common Stock issued to Board of Directors and
   employees

—

1,581

—

—

—

1,581

Currency translation, net

—

—

—

(4,251
)

—

(4,251
)
Foreign currency hedge, net

—

—

—

599

—

599

Net income

—

—

—

—

8,414

8,414

Balance at March 31, 2019

33,653

$
134,486

$
14,513

$
(43,152
)
$
372,640

$
478,487

Stock repurchase

(630
)

(25,000
)

—

—

—

(25,000
)
Exercise of Common Stock options for cash

116

4,936

(379
)

—

—

4,557

Cancellation of restricted stock

(21
)

(550
)

—

—

—

(550
)
Stock option compensation

—

—

(114
)

—

—

(114
)
Common Stock issued to Board of Directors and
   employees

30

1,438

—

—

—

1,438

Currency translation, net

—

—

—

3,480

—

3,480

Foreign currency hedge, net

—

—

—

232

—

232

Net income

—

—

—

—

2,751

2,751

Balance at June 30, 2019

33,148

$
115,310

$
14,020

$
(39,440
)
$
375,391

$
465,281

Stock repurchase

(635
)

(25,000
)

—

—

—

(25,000
)
Exercise of Common Stock options for cash

228

12,201

(3,093
)

—

—

9,108

Cancellation of restricted stock

(12
)

(287
)

—

—

—

(287
)
Stock option compensation

—

—

421

—

—

421

Common Stock issued to Board of Directors and
   employees

13

1,557

—

—

—

1,557

Currency translation, net

—

—

—

(15,172
)

—

(15,172
)
Foreign currency hedge, net

—

—

—

(202
)

—

(202
)
Net income

—

—

—

—

15,887

15,887

Balance at September 30, 2019

32,742

$
103,781

$
11,348

$
(54,814
)
$
391,278

$
451,593

~~See accompanying notes to the consolidated condensed financial statements.~~

~~GENTHERM INCORPORATED~~

~~CONSOLIDATED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (continued)~~

~~(In thousands)~~

~~(Unaudited)~~

Accumulated

Other

Common Stock

Paid-in

Comprehensive

Accumulated

Shares

Amount

Capital

Income (Loss)

Earnings

Total

Balance at December 31, 2017

36,761

$
265,048

$
15,625

$
(20,444
)
$
293,645

$
553,874

Cumulative effect of accounting change due to
   adoption of ASU 2014-09

—

—

—

—

(3,264
)

(3,264
)
Cumulative effect of accounting change due to
   adoption of ASU 2016-16

—

—

—

—

31,645

31,645

Cumulative effect of accounting change due to
   adoption of ASU 2018-02

—

—

—

(40
)

40

—

Exercise of Common Stock options for cash

57

1,061

(310
)

—

—

751

Cancellation of restricted stock

(24
)

(659
)

—

—

—

(659
)
Stock option compensation

—

—

840

—

—

840

Common stock issued to Board of Directors and
   employees

—

1,362

—

—

—

1,362

Currency translation, net

—

—

—

11,665

—

11,665

Foreign currency hedge, net

—

—

—

1,545

—

1,545

Commodity hedge, net

—

—

—

(277
)

—

(277
)
Net income

—

—

—

—

12,966

12,966

Balance at March 31, 2018

36,794

266,812

16,155

(7,551
)

335,032

610,448

Stock repurchase

(629
)

(20,241
)

—

—

—

(20,241
)
Exercise of Common Stock options for cash

241

5,335

(1,120
)

—

—

4,215

Cancellation of restricted stock

(25
)

(223
)

—

—

—

(223
)
Stock option compensation

—

—

803

—

—

803

Common stock issued to Board of Directors and
   employees

20

1,057

—

—

—

1,057

Currency translation, net

—

—

—

(23,150
)

—

(23,150
)
Foreign currency hedge, net

—

—

—

(1,142
)

—

(1,142
)
Net income

—

—

—

—

16,659

16,659

Balance at June 30, 2018

36,401

252,740

15,838

(31,843
)

351,691

588,426

Stock repurchase

(938
)

(47,111
)

—

—

—

(47,111
)
Exercise of Common Stock options for cash

284

11,466

(2,368
)

—

—

9,098

Stock option compensation

—

—

823

—

—

823

Common stock issued to Board of Directors and
   employees

2

1,474

—

—

—

1,474

Currency translation, net

—

—

—

(3,251
)

—

(3,251
)
Foreign currency hedge, net

—

—

—

1,217

—

1,217

Net income

—

—

—

—

(355
)

(355
)
Balance at September 30, 2018

35,749

$
218,569

$
14,293

$
(33,877
)
$
351,336

$
550,321

										Accumulated
										Other
	Common Stock						Paid-in			Comprehensive			Accumulated
	Shares			Amount			Capital			Loss			Earnings		Total
Balance at December 31, 2019		32,674		$	102,507		$	10,852		$	(42,441	)	$	401,732	$	472,650
Stock repurchase		(246	)		(9,092	)		—			—			—		(9,092	)
Exercise of Common Stock options for cash		162			7,374			(1,472	)		—			—		5,902
Cancellation of restricted stock		(1	)		(404	)		—			—			—		(404	)
Stock option compensation		—			—			268			—			—		268
Common Stock issued to Board of Directors and employees		10			1,674			—			—			—		1,674
Other comprehensive loss		—			—			—			(12,490	)		—		(12,490	)
Net income		—			—			—			—			11,873		11,873
Balance at March 31, 2020		32,599		$	102,059		$	9,648		$	(54,931	)	$	413,605	$	470,381

										Accumulated
										Other
	Common Stock						Paid-in			Comprehensive			Accumulated
	Shares			Amount			Capital			Loss			Earnings		Total
Balance at December 31, 2018		33,857		$	140,300		$	14,934		$	(39,500	)	$	363,965	$	479,699
Cumulative effect of accounting change due to adoption of ASU 2016-02		—			—			—			—			261		261
Stock repurchase		(200	)		(8,040	)		—			—			—		(8,040	)
Exercise of Common Stock options for cash		13			1,021			(807	)		—			—		214
Cancellation of restricted stock		(17	)		(376	)		—			—			—		(376	)
Stock option compensation		—			—			386			—			—		386
Common Stock issued to Board of Directors and employees		—			1,581			—			—			—		1,581
Other comprehensive loss		—			—			—			(3,652	)		—		(3,652	)
Net income		—			—			—			—			8,414		8,414
Balance at March 31, 2019		33,653		$	134,486		$	14,513		$	(43,152	)	$	372,640	$	478,487

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

Note 1 – Overview

Gentherm Incorporated is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Unless the context otherwise requires, the terms “Gentherm”, “Company”, “we”, “us” and “our” used herein refer to Gentherm Incorporated and its consolidated subsidiaries. Our products provide solutions for automotive passenger climate comfort and convenience, battery thermal management and cell connecting systems, as well as patient temperature management within the health care industry. Our automotive products can be found onin the vehicles of nearly all major automotive manufacturers operating in North America and Europe, and several major automotive manufacturers in Asia. ~~We operate~~The Company operates in locations aligned with ~~our~~its major customers’ product strategies to provide locally enhanced design, integration and production ~~capabilities and to identify future thermal technology product opportunities in both automotive and other markets.~~capabilities. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets.

On February 1, 2019, the Company completed the divestiture of its environmental test equipment business, Cincinnati Sub Zero industrial chamber business (“CSZ-IC”) and on October 1, 2019, the Company completed the divestiture of its remote power generation systems business, Gentherm Global Power Technologies (“GPT”). The Company’s consolidated condensed financial statements herein include the results of CSZ-IC and GPT through their respective dates of divestiture. CSZ-IC and GPT are not subject to discontinued operations classification.

On April 1, 2019, Gentherm acquired Stihler Electronic GmbH (“Stihler”), a leading developer and manufacturer of patient and blood temperature management systems. The acquisition was accounted for as a business combination.

Basis of Presentation

The unaudited consolidated condensed financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations. The information furnished in the consolidated condensed financial statements include all adjustments (consisting of only normal, recurring adjustments), considered necessary to present fairly the results of operations, financial position and cash flows of the Company. These financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2018.~~2019. The operating results for interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year.

Certain amounts in the prior period’s financial statements have been reclassified to conform with the current period presentation. Notably, $2,565 and $7,883 in customer relationship amortization was reclassified from product revenues to selling, general and administrative expenses for the three and nine months ended September 30, 2018, respectively.

In preparing these financial statements, management was required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are based on our historical experience, the terms of existing contracts, our evaluation of trends in the industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate. ~~However, these~~These estimates and assumptions are subject to an inherent degree of uncertainty. We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates, judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained. As a result, actual results ~~in these areas~~ may differ significantly from our ~~estimates.~~estimates, and any such differences may be material to our financial statements.

Note 2 – New Accounting Pronouncements

Recently Adopted Accounting Pronouncements

~~Leases~~

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standard Update (“ASU”) 2016-02, “Leases (Topic 842)” (as amended, “ASU 2016-02”). ASU 2016-02 requires lessees to recognize a lease liability and a right-of-use asset on the balance sheet for all leases, except for short-term leases with terms of twelve months or less. The lease liability represents the lessee’s obligation to make lease payments arising from a lease, and is measured as the present value of the lease payments. The right-of-use asset represents the lessee’s right to use a specified asset for the lease term, and is measured at the lease liability amount, adjusted for lease prepayment, lease incentives received and the lessee’s initial direct costs. Leases are to be classified as finance or operating leases, with classification affecting the pattern and classification of expense recognition in the statement of income (loss).

~~The Company adopted ASU 2016-02 on January 1, 2019, by applying the modified retrospective method and recognized a cumulative-effect adjustment to the opening balance in retained earnings.~~ ~~Financial information has not been updated and disclosure under the new standard have not been provided to dates and periods before January 1, 2019~~, and the Company’s reporting for the comparative periods in the consolidated financial statements will continue to be in accordance with Accounting Standards Codification Topic 840, Leases (“ASC 840”).

~~GENTHERM INCORPORATED~~

~~NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS~~

~~(In thousands, except share and per share data)~~

~~(Unaudited)~~

ASU 2016-02 did not have an impact on our consolidated condensed statements of income for the three and nine months ended September 30, 2019, but had a significant impact on our consolidated condensed balance sheet as of September 30, 2019. The cumulative effects of the changes made to the Company’s consolidated condensed balance sheet as of January 1, 2019 for the adoption of ASU 2016-02 were as follows:

Balance as of
December 31,
2018

Adjustments
due to adoption
of ASU 2016-02

Balance as of
January 1,
2019

Prepaid expenses and other assets

54,271

(74
)

54,197

Assets held for sale

69,699

4,127

73,826

Operating lease right-of-use assets

—

13,019

13,019

Liabilities held for sale

13,062

4,136

17,198

Deferred tax liabilities

1,177

114

1,291

Non-current lease liabilities

—

12,561

12,561

Accumulated earnings

363,965

261

364,226

The Company elected the package of practical expedients provided in ASU 2016-02, which permits a lessee to not reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. Gentherm elected the use-of-hindsight to determine whether lease terms included periods covered by the lessee’s option to extend or terminate a lease, whether to purchase the underlying asset at the end of the lease agreement, and in assessing impairment of operating lease right-of-use assets. Finally, Gentherm elected to not assess whether existing or expired land easements that were not previously accounted for as leases are or contain a lease. Land easements previously accounted for as leases were not eligible for this practical expedient.

~~Recently Issued Accounting Pronouncements Not Yet Adopted~~

Expected Credit Losses

In June 2016, the ~~FASB~~Financial Accounting Standard Board (“FASB”) issued ~~ASU~~Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 requires ~~the~~ measurement and recognition of ~~all~~ expected credit losses for financial assets ~~held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts.~~held. ASU 2016-13 is effective for annual and interim periods beginning after December 15, 2019. ~~Early adoption of the amendments in this update is permitted. We are currently in the process of determining the impact the implementation of~~The Company adopted ASU 2016-13 ~~will have~~as of January 1, 2020 and there was no significant

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

impact on ~~the Company’s~~its consolidated condensed financial statements and ~~note disclosures.~~related disclosures as a result. The Company considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic and determined that the estimate of credit losses was not significantly impacted.

Cloud Computing Arrangements That Are Service Contracts

In August 2018, the FASB issued ASU 2018-15, “Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” ASU 2018-15 requires implementation costs incurred by customers in cloud computing arrangements to be deferred and recognized over the term of the arrangement if those costs would be capitalized by the customer in a software licensing arrangement under the internal-use software guidance. ASU 2018-15 is effective for annual and interim periods beginning after December 15, 2019. ~~Early adoption of the amendments in this update is permitted. We are currently in the process of determining the impact the implementation of~~The Company adopted ASU 2018-15 ~~will have~~as of January 1, 2020 and there was no significant impact on ~~the Company’s~~its consolidated condensed financial statements and ~~note disclosures.~~

~~Retirement Benefits~~

In August 2018, the FASB issued ASU 2018-14, “Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20): Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans.” ASU 2018-14 removes certain disclosure requirements, including (i) the amounts in accumulated other comprehensive income expected to be recognizedrelated disclosures as components of net periodic benefit cost over the next fiscal year, and (ii) the amount and timing of plan assets expected to be returned to the employer. ASU 2018-14 also adds new disclosure requirements, including (i) the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates and (ii) an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. ASU 2018-14 is effective for annual periods

~~GENTHERM INCORPORATED~~

~~NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS~~

~~(In thousands, except share and per share data)~~

~~(Unaudited)~~

ending after December 15, 2020. Early adoption of the amendments in this update is permitted. We are currently in the process of determining the impact the implementation of ASU 2018-14 will have on the Company’s financial statement note disclosures.a result.

Fair Value Measurement

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 removes certain disclosure requirements, including (i) the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, (ii) the policy for timing of transfer between levels, and (iii) the valuation processes for Level 3 fair value measurements. ASU 2018-13 also adds new disclosure requirements, including (i) the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and (ii) the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019. The Company adopted ASU 2018-13 as of January 1, 2020 and there was no significant impact on its consolidated condensed financial statements and related disclosures as a result.

Recently Issued Accounting Pronouncements Not Yet Adopted

Retirement Benefits

In August 2018, the FASB issued ASU 2018-14, “Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20): Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans.” ASU 2018-14 removes certain disclosure requirements, including (i) the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year, and (ii) the amount and timing of plan assets expected to be returned to the employer. ASU 2018-14 also adds new disclosure requirements, including (i) the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates and (ii) an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. ASU 2018-14 is effective for annual periods ending after December 15, 2020. Early adoption of ~~disclosures that are removed~~the amendments in this update is ~~permitted, but adoption~~permitted. The Company is ~~delayed for the new additional disclosures until their effective date. We are~~ currently in the process of determining the impact the implementation of ASU ~~2018-13~~2018-14 will have on the Company’s financial statement note disclosures.

Income Taxes

In December 2019, the FASB issued Accounting Standard Update ASU No. 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes". This ASU simplifies the accounting for income taxes by removing certain exceptions previously included in the guidance. In addition, the ASU provides new guidance on accounting for specific taxes and minor codification improvements. ASU 2019-12 is effective for annual periods ending after December 15, 2020. Early adoption of the amendments in this update is permitted. The Company is currently in the process of determining the impact the implementation of ASU 2019-12 will have on the Company’s financial statement note disclosures.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

Note 3 – Acquisitions and Divestitures

In June 2018, Gentherm announced a new strategic plan. An important element of the strategy was the elimination of investments in non-core areas, including GPT and CSZ-IC.

Divestiture of ~~Cincinnati Sub-Zero Industrial Chamber Business (CSZ-IC)~~CSZ-IC

On February 1, 2019, ~~as part of~~ the ~~Company’s Fit-for-Growth initiative to eliminate investments in non-core businesses, we~~Company completed the sale of CSZ-IC and the ~~Cincinnati Sub-Zero industrial chamber business (“CSZ-IC”) and~~ former Cincinnati Sub-Zero headquarters facility to Weiss Technik North America, Inc. for total cash proceeds of $47,500, including $2,500 of cash proceeds placed into an escrow account for a period of up to one year as partial security for the Company’s obligations under the sale agreement. The cash proceeds held in escrow are recorded as restricted cash within the consolidated condensed balance sheets. In connection with the sale, Gentherm entered into an operating lease agreement for a portion of the office and manufacturing building space purchased by Weiss Technik North America, Inc. The Company recognized a $4,970 pre-tax gain on the sale of CSZ-IC during the ~~nine~~three months ended ~~September 30,~~March 31, 2019, which is classified as Gain on sale of business within the consolidated condensed statements of income. In January 2020, claims were made against the cash proceeds held in the escrow account, which has been maintained in escrow following the expiration of the one-year escrow period. The Company is not able to estimate the possible loss, if any, of amounts held in escrow in connection with this matter.

Divestiture of GPT

During 2018, the Company determined that GPT met the held for sale criteria. During the three months ended March 31, 2019, the Company continued to assess the fair value of the GPT disposal group, less costs to sell, at each reporting period. As a result of these fair value measurements, the Company recorded impairment loss of $6,998 for the three months ended March 31, 2019. Additionally, during the three months ended March 31, 2019, the Company determined an equity investment met the held for sale criteria and recognized impairment loss of $3,486. On October 1, 2019, the Company completed the sale of GPT for a nominal amount.

Acquisition of Stihler ~~Electronic GmbH~~

On April 1, 2019, Gentherm acquired Stihler ~~Electronic GmbH (“Stihler”), a leading developer and manufacturer of patient and blood temperature management systems,~~ for a purchase price of $15,476, net of cash acquired and including $653 of contingent consideration to be paid upon achievement of a milestone that must be completed by September 2020. In addition, the purchase agreement includes a contingent payment of $653 to be paid if the selling shareholder remains employed by Stihler through December 2020. This amount ~~will be recorded~~is being recognized as a component of selling, general and administrative expenses ratably over the service period. The results of operations of Stihler ~~are~~were reported within the Company’s Industrial segment from the date of acquisition. During the three and nine months ended September 30, 2019, the Company incurred acquisition-related costs of approximately $19 and $399, respectively. These amounts were recorded as incurred, within the Company's consolidated statements of income.

~~GENTHERM INCORPORATED~~

~~NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS~~

~~(In thousands, except share and per share data)~~

~~(Unaudited)~~

The acquisition was accounted for as a business combination, with the total purchase price allocated on a preliminary basis using information available in the second quarter of 2019. The preliminary purchase price and related allocation to the acquired net assets of Stihler, based on their estimated fair values as of the acquisition date, are shown below:

Purchase price, cash consideration, net of cash acquired

$
14,823

Purchase price, fair value of contingent consideration

653

Total purchase price, net of cash acquired

15,476

Accounts receivable

$
883

Inventory

1,698

Prepaid expenses and other assets

241

Operating lease right-of-use assets

263

Property and equipment

260

Other intangible assets

4,380

Goodwill

9,816

Assumed liabilities

(2,065
)
Net assets acquired

$
15,476

Other intangible assets primarily include amounts recognized for the fair value of customer-related intangible assets, which will be amortized over their estimated useful lives of approximately 9 years. The estimated fair value of these assets was based on third-party valuations and management’s estimates, generally utilizing an income approach. Goodwill recognized in this transaction is primarily attributable to intangible assets that do not qualify for separate recognition. It is estimated that $2,524 of the goodwill recognized will be deductible for income tax purposes.

combination. The purchase price and related allocation ~~are preliminary and could be revised for up to one year from~~were finalized in the ~~acquisition date as a result~~fourth quarter of adjustments made to the purchase price, additional information obtained regarding liabilities assumed, including, but not limited to, contingent liabilities, revisions of provisional estimates of fair values, including, but not limited to, the completion of independent appraisals and valuations related to property, plant and equipment and intangible assets, and certain tax attributes.

2019. The pro forma effect of the Stihler acquisition does not materially impact the Company’s reported results for any period presented, and as a result no pro forma financial statements are presented.

~~GENTHERM INCORPORATED~~

~~NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS~~

~~(In thousands, except share and per share data)~~

~~(Unaudited)~~

Note 4 ~~– Assets and Liabilities Held for Sale~~

~~During 2018, the Company determined that its Gentherm Global Power Technologies (“GPT”) business met the held for sale criteria and recognized $2,190 in impairment loss.~~

During 2019, the Company continued to assess the fair value of the GPT disposal group, less costs to sell, at each reporting period. As a result of these fair value measurements, the Company recorded additional impairment losses of $837 and $16,720 for the three and nine months ended September 30, 2019, respectively. Additionally, during the first quarter of 2019, the Company determined that an equity investment met the held for sale criteria and recognized impairment losses of $0 and $4,486 for the three and nine months ended September 30, 2019, respectively.

Subsequent to the end of the Company's third quarter, effective October 1, 2019, the Company completed the divesture of GPT. The Company expects to record approximately $6,000 pre-tax loss on sale, in the fourth quarter of 2019, which includes approximately $4,000 related to the release of previously deferred foreign currency translation losses recorded in accumulated other comprehensive loss.

~~The assets and liabilities of the GPT disposal group classified as held for sale as of September 30, 2019 are as follows:~~

Cash

$
1,422

Accounts receivable, net

2,238

Inventory, net

4,936

Prepaid expenses and other assets

215

Operating lease right-of-use assets

3,926

Investment

—

Property and equipment, net

7,356

Other intangible assets, net

1,033

Deferred income tax assets

4,371

Impairment loss

(18,910
)
Total assets held for sale

$
6,587

Accounts payable

420

Accrued liabilities

2,238

Operating lease liabilities

3,929

Total liabilities held for sale

$
6,587

The equity investment described above, does not have a readily determinable fair value and is measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer.

~~Note 5~~ – Restructuring

Manufacturing Footprint Rationalization

On September 23, 2019, the Company committed to a restructuring plan to improve the Company’s manufacturing productivity and rationalize its footprint. Under this plan, the Company will relocate and consolidate certain existing automotive manufacturing and, as a result, ~~certain other activities, overall reducing~~reduce the number of plants by two. On March 20, 2020, the Company announced the initial phase of this restructuring plan, which includes the consolidation of all North American electronics manufacturing to Celaya, Mexico. This will result in the closure of the Burlington, Canada facility, and the transfer of electronics manufacturing from Acuña, Mexico.

During the ~~third quarter of 2019,~~three months ended March 31, 2020, the Company recognized restructuring expense of ~~$5,200~~$248 for employee separation costs ~~that will be paid pursuant to~~and $242 for accelerated depreciation. The Company has recorded approximately $7,440 of restructuring expenses since the ~~terms~~inception of ~~statutory requirements of the affected locations. Additionally, the Company recognized $1,612 of accelerated depreciation~~this program.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and ~~fixed asset impairment.~~per share data)

(Unaudited)

The Company expects to incur total costs of between $20,000 and $24,000, of which between $17,000 and $21,000 are expected to be cash expenditures. The total expected costs include employee separation costs of between $9,000 and $11,000, capital expenditures of between $4,500 and $5,500 and non-cash expenses for accelerated depreciation and impairment of fixed assets of approximately $3,000. The Company also expects to incur other transition costs including recruiting, relocation, and machinery and equipment move and set up costs of between $3,500 and $4,500. The actions under this plan are expected to be substantially completed by the end of 2021. The actual timing, costs and savings of the ~~Plan~~plan may differ materially from the Company’s current expectations and estimates.

~~GENTHERM INCORPORATED~~

~~NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS~~

~~(In thousands, except share and per share data)~~

~~(Unaudited)~~

Other Restructuring Activities

As part of the Company’s continued efforts to optimize its cost structure, the Company has undertaken several discrete restructuring actions. During the three ~~and nine~~ months ended ~~September 30,~~March 31, 2020 and 2019, the Company recognized ~~$1,467~~$3,054 and ~~$2,726~~$395 of employee separation costs, respectively, and ~~$385~~$222 and ~~$734~~$4 of other related costs, respectively. In addition, during the three months ended March 31, 2019, the Company recognized $425 of asset impairment loss. These restructuring expenses were primarily associated with restructuring actions focused on the rotation of our manufacturing footprint to lower cost locations and the reduction of global overhead costs. These discrete restructuring actions are expected to approximate the total cumulative costs for those actions. The Company will continue to explore opportunities to improve its future profitability and competitiveness. These actions may result in the recognition of additional restructuring charges that could be material.

GPT and CSZ-IC

Costs associated with the divestiture process were classified as restructuring. During the three ~~and nine~~ months ended ~~September 30, 2018,~~March 31, 2019, the Company recognized ~~$3,303 and $5,040~~$251 of employee separation costs, ~~respectively,~~ and ~~$1,332 and $2,831~~$839 of other related costs, ~~respectively.~~

~~Advanced Research~~related to the marketing of GPT and ~~Development Rationalization and Site Consolidation~~

In June 2018, Gentherm completed the sale of its battery management systems division located in Irvine, California. A loss on the sale of $1,107 was recognized in restructuring expenses during nine months ended September 30, 2018. An additional asset impairment loss of $0 and $425 was recognized during the three and nine months ended September 30, 2019.

During the three and nine months ended September 30, 2018, Gentherm recognized employees separation costs of $157 and $1,038, respectively, and $589 and $1,024 of other related costs associated with the closure of 2 leased facilities located in Azusa, California. ~~The Company also recognized $50 and $1,250 for the three and nine months ended September 30, 2018, for the disposal of long-lived assets controlled and used in Azusa, California.~~

CSZ-IC, which were classified as restructuring. The Company has recorded approximately ~~$4,669~~$2,303 of restructuring expenses since inception of this program and it is considered complete.

~~GPT and CSZ-IC~~

~~During 2018, Gentherm launched a program to actively market GPT and CSZ-IC. Costs associated with the divestiture process were classified as restructuring.~~

~~During the three and nine months ended September 30, 2019, the Company recognized $0 and $251 of employee separation costs, respectively, and $0 and $861 of other related costs, respectively.~~

~~During the three and nine months ended September 30, 2018, the Company recognized $262 and $472 of employee separation costs, and $125 and $125 of other related costs, respectively.~~

~~The Company has recorded approximately $2,173 of restructuring expenses since inception of this program and it is considered substantially complete.~~

Restructuring Expenses By Reporting Segment

The following table summarizes restructuring ~~activity~~expense for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2020 and 2019 ~~and 2018~~ by reporting segment:

	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
	2019		2018		2019		2018		2020		2019
Automotive	$	7,820	$	2,919	$	9,016	$	4,038	$	3,122	$	368
Industrial		88		1,486		1,689		5,320		96		1,546
Reconciling Items		756		1,413		1,104		3,540
Reconciling items										548		—
Total	$	8,664	$	5,818	$	11,809	$	12,898	$	3,766	$	1,914

~~GENTHERM INCORPORATED~~

~~NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS~~

~~(In thousands, except share and per share data)~~

~~(Unaudited)~~

Restructuring Liability

Restructuring liabilities are classified as accrued liabilities on the consolidated condensed balance sheets. The following table summarizes restructuring ~~activity~~liability for the ~~nine~~three months ended ~~September 30, 2019:~~March 31, 2020:

	Employee Separation Costs			Accelerated Depreciation and Asset Impairment Charges			Other related costs			Total			Employee Separation Costs			Accelerated Depreciation Charges			Other Related Costs			Total
Balance at December 31, 2018	$	2,079		$	—		$	468		$	2,547
Balance at December 31, 2019													$	5,994		$	—		$	71		$	6,065
Additions, charged to restructuring expenses		8,177			2,037			1,595			11,809			3,302			242			222			3,766
Cash payments		(4,069	)		—			(1,458	)		(5,527	)		(1,932	)		—			(202	)		(2,134	)
Non-cash utilization		—			(2,037	)		—			(2,037	)		—			(242	)		—			(242	)
Reclassification to lease liability		—			—			(193	)		(193	)
Balance at September 30, 2019	$	6,187		$	—		$	412		$	6,599
Currency translation														(306	)		—			38			(268	)
Balance at March 31, 2020													$	7,058		$	—		$	129		$	7,187

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

Note 65 – Earnings Per Share

Basic earnings per share are computed by dividing net income by the weighted average number of shares of ~~stock~~Common Stock outstanding during the period. The Company’s diluted earnings per share give effect to all potential shares of Common Stock outstanding during a period that do not have an anti-dilutive impact to the calculation. In computing the diluted earnings per share, the treasury stock method is used in determining the number of shares assumed to be issued from the exercise of Common Stock equivalents.

The following ~~summarizes~~table illustrates earnings per share and the ~~Common Stock included~~weighted average shares outstanding used in ~~the~~calculating basic and diluted ~~shares, as disclosed on the face of the consolidated condensed statements of income:~~

earnings per share:

Three Months Ended
September 30,

Nine Months Ended
September 30,

2019

2018

2019

2018

Weighted average number of shares for calculation of basic
   EPS

32,838,636

36,103,520

33,282,584

36,364,380

Stock options, restricted stock awards and restricted stock
   units under equity incentive plans

94,043

344,642

135,971

105,379

Weighted average number of shares for calculation of
   diluted EPS

32,932,679

36,448,162

33,418,555

36,469,759

	Three Months Ended March 31,
	2020		2019
Net income	$	11,873	$	8,414

Basic weighted average shares of Common Stock outstanding		32,692,895		33,573,411
Dilutive effect of stock options, restricted stock awards and restricted stock units		176,254		159,924
Diluted weighted average shares of Common Stock outstanding		32,869,149		33,733,335

Basic earnings per share	$	0.36	$	0.25
Diluted earnings per share	$	0.36	$	0.25

The following table represents Common Stock issuable upon the exercise of certain stock options that have been excluded from the diluted earnings calculation because the effect of their inclusion would be anti-dilutive.

Three Months Ended
September 30,

Nine Months Ended
September 30,

2019

2018

2019

2018

Stock options outstanding for equity incentive plans

441,435

12,000

441,435

1,359,250

	Three Months Ended March 31,
	2020		2019
Anti-dilutive securities share impact		682,741		396,500

~~GENTHERM INCORPORATED~~

~~NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS~~

~~(In thousands, except share and per share data)~~

~~(Unaudited)~~

Note 76 – Segment Reporting

Segment information is used by management for making strategic operating decisions for the Company. Management evaluates the performance of the Company’s segments based primarily on operating income or loss.

The Company’s reportable segments are as follows:

•

Automotive – this segment represents the design, development, manufacturing and sales of automotive climate ~~control seat (CCS) products, seat heaters, steering wheel heaters,~~comfort systems, specialized automotive ~~cables,~~cable systems, battery thermal management, ~~(BTM), electronics~~ and ~~other~~ automotive ~~products.~~electronic systems.

•

Industrial – this segment represents the combined ~~operating~~ results offrom our patient temperature management systems business (“Medical”), GPT ~~Gentherm Medical~~(through October 1, 2019), CSZ-IC (through February 1, 2019) and Gentherm’s advanced research and development division. ~~We perform advanced research~~The operating results from these businesses and ~~development~~division are presented together as one reporting segment because of their historical joint concentration on identifying new markets and product applications based on thermal management systems, including those that utilize new proprietary comfort software algorithms, to enhance the efficiency and functionality of our automotive heating and cooling products. Unlike research and development that relates to a specific product application for a customer, advanced research and development activities affect products and technologies that are not currently generating product revenues. The segment includes government sponsored research projects.technologies.

•

Reconciling Items – ~~include~~includes corporate selling, general and administrative costs and acquisition transaction costs.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

The tables below present segment information about the reported product revenues, depreciation and amortization and operating income (loss) of the Company for three ~~and nine~~ months ended ~~September 30, 2019~~March 31, 2020 and ~~2018. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level.~~2019.

Three Months Ended September 30,	Automotive		Industrial⁽¹⁾			Reconciling Items			Consolidated Total
Three Months Ended March 31,											Automotive		Industrial			Reconciling Items			Consolidated Total
2020:
Product revenues											$	216,472	$	12,141		$	—		$	228,613
Depreciation and amortization												9,524		507			375			10,406
Operating income (loss)												31,706		(605	)		(12,400	)		18,701
2019:
Product revenues	$	228,243	$	11,813		$	—		$	240,056	$	242,357	$	15,564		$	—		$	257,921
Depreciation and amortization		10,170		480			414			11,064		10,296		290			466			11,052
Operating income (loss)		36,629		(3,496	)		(12,804	)		20,329		39,896		(4,514	)		(13,537	)		21,845
2018:
Product revenues⁽¹⁾	$	238,849	$	22,655		$	—		$	261,504
Depreciation and amortization		11,060		1,170			668			12,898
Operating income (loss)		37,908		(4,335	)		(17,860	)		15,713

Nine Months Ended September 30,

Automotive

Industrial⁽¹⁾

Reconciling
Items

Consolidated
Total

2019:

Product revenues

$
700,300

$
41,003

$
—

$
741,303

Depreciation and amortization

30,660

1,319

1,302

33,281

Operating income (loss)

114,456

(12,131
)

(40,094
)

62,231

2018:

Product revenues⁽¹⁾

$
724,420

$
68,070

$
—

$
792,490

Depreciation and amortization

32,839

3,822

2,060

$
38,721

Operating income (loss)

116,312

(18,896
)

(45,461
)

51,955

~~(1)~~

Industrial segment includes $3,418 and $30,460 in product revenues, $0 and $1,894 in depreciation and amortization, and $206 and $659 in operating income from CSZ-IC for the nine months ended September 30, 2019 and 2018, respectively.

~~GENTHERM INCORPORATED~~

~~NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS~~

~~(In thousands, except share and per share data)~~

~~(Unaudited)~~

Automotive and Industrial segment product revenues by product category for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2020 and 2019 ~~and 2018 are~~were as follows:

Three Months Ended
September 30,

Nine Months Ended
September 30,

2019

2018

2019

2018

Climate Control Seats (CCS)

$
88,133

$
97,578

$
270,924

$
276,191

Seat Heaters

71,030

70,768

218,578

235,164

Steering Wheel Heaters

16,621

18,095

49,620

53,192

Automotive Cables

20,361

24,961

66,316

77,471

Battery Thermal Management (BTM)^(a)

11,890

7,461

31,531

18,863

Electronics

11,729

12,590

36,035

44,409

Other Automotive

8,479

7,396

27,296

19,130

Subtotal Automotive

$
228,243

$
238,849

$
700,300

$
724,420

Remote Power Generation (GPT)

3,477

4,378

11,181

14,310

Industrial Chambers

—

9,829

3,418

30,460

Gentherm Medical

8,336

8,448

26,404

23,300

Subtotal Industrial

$
11,813

$
22,655

$
41,003

$
68,070

Total Company

$
240,056

$
261,504

$
741,303

$
792,490

a)	Battery Thermal Management or BTM product revenues include Gentherm’s automotive grade, low cost, heat resistant fans and blowers used by customer for battery cooling through ventilation and production level shipments of the advanced TED based active cool system.

	Three Months Ended
	March 31,
	2020		2019
Climate Control Seats (CCS)	$	82,528	$	94,354
Seat Heaters		64,532		73,920
Automotive Cables		22,140		23,749
Steering Wheel Heaters		19,235		16,970
Battery Thermal Management (BTM)		11,209		10,745
Electronics		10,376		12,852
Other Automotive		6,452		9,767
Subtotal Automotive		216,472		242,357
Medical		12,141		8,187
GPT		—		3,959
CSZ-IC		—		3,418
Subtotal Industrial		12,141		15,564
Total Company	$	228,613	$	257,921

Total product revenues information by geographic area is as follows (based on shipment destination):

									Three Months Ended
	Three Months Ended September 30,				Nine Months Ended September 30,				March 31,
	2019		2018		2019		2018		2020		2019
United States	$	111,570	$	125,936	$	340,656	$	369,798	$	105,918	$	118,454
Germany		20,379		22,681		63,889		68,670		16,830		23,210
South Korea										16,417		14,978
Japan		20,508		16,672		59,102		43,520		16,137		18,591
China		17,591		22,756		49,598		71,887		13,003		15,597
South Korea		14,543		12,814		45,098		42,419
Czech Republic		8,805		10,742		30,956		33,563		10,073		12,142
Canada		8,833		7,778		29,226		33,482		8,262		10,291
Romania										7,659		6,922
United Kingdom		8,315		9,037		23,980		28,349		6,964		8,832
Other		29,512		33,088		98,798		100,802		27,350		28,904
Total Non-U.S.	$	128,486	$	135,568	$	400,647	$	422,692	$	122,695	$	139,467
	$	240,056	$	261,504	$	741,303	$	792,490
Total Company									$	228,613	$	257,921

1713

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

Note 87 – Revenue Recognition

Contract Balances

The Company has no material contract assets. The Company’s contract liabilities are comprised of material rights in the Automotive segment.

The aggregate amount of transaction price allocated to material rights that ~~remain~~remained unsatisfied as of ~~September 30, 2019 is $747. We expect~~March 31, 2020 was $186. The Company expects to recognize into revenue, ~~42%~~23% of this unearned revenue balance induring the ~~next 3 months,~~remainder of 2020, and the remaining ~~33%~~28%, ~~9%, 9%~~27% and 7%22% in ~~2020,~~ 2021, 2022 and 2023, respectively.

~~Unearned revenue related to the Automotive segment was $747 and $1,597 as of September 30, 2019 and December 31, 2018, respectively.~~

Changes in the unearned revenue balance during the three months ended March 31, 2020 were as follows:

Nine Months Ended September 30, 2019

Balance, beginning of period

$
1,597

Additions to unearned revenue

549

Reclassified to revenue

(1,211
)
Reclassified to held for sale

(168
)
Currency impacts

(20
)
Balance, end of period

$
747

Balance as of December 31, 2019	$	579
Additions to unearned revenue		—
Reclassified to revenue		(389	)
Currency impacts		(4	)
Balance as of March 31, 2020	$	186

~~Revenue allocated~~Assets Recognized from the Costs to ~~remaining performance obligations represents contracted revenue that has not yet been recognized, which includes unearned revenue and amounts that will~~Obtain a Contract with a Customer

The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if the benefits of those costs are expected to be ~~invoiced and recognized as revenue in future periods.~~

realized for a period greater than one year. Total capitalized costs to obtain a contract ~~that~~ were ~~recognized on the consolidated condensed balance sheets~~$1,800 and $1,893 as of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018 were immaterial.~~

2019, respectively. These amounts are recorded in other current assets and are being amortized into product revenues over the expected production life of the program.

Note 98 – Income Taxes

At the end of each interim period, the Company makes its best estimate of the annual expected effective income tax rate and applies that rate to its ordinary year-to-date earnings or loss. The income tax provision or benefit related to unusual or infrequent items, if applicable, that will be separately reported or reported net of their related tax effects are individually computed and recognized in the interim period in which those items occur. In addition, the effect of changes in enacted tax laws or rates, tax status, judgment on the realizability of a beginning-of-the-year deferred tax asset in future years or income tax contingencies is recognized in the interim period in which the change occurs.

The computation of the annual expected effective income tax rate at each interim period requires certain estimates and assumptions including, but not limited to, the expected pre-tax income (or loss) for the year, projections of the proportion of income (and/or loss) earned and taxed in respective jurisdictions, permanent and temporary differences, and the likelihood of the realizability of deferred tax assets generated in the current year. Jurisdictions with a projected loss for the year or a year-to-date loss for which no tax benefit or expense can be recognized due to a valuation allowance are excluded from the estimated annual effective tax rate. The impact of such an exclusion could result in a higher or lower effective tax rate during a particular quarter, based upon the composition and timing of actual earnings compared to annual projections. The estimates used to compute the provision or benefit for income taxes may change as new events occur, additional information is obtained or as our tax environment changes. To the extent that the expected annual effective income tax rate changes, the effect of the change on prior interim periods is included in the income tax provision in the period in which the change in estimate occurs.

18On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was signed into U.S. law. The CARES Act provides a stimulus and assistance package intended to address the impact of the COVID-19 pandemic, including tax relief and government loans, grants and investments. As permitted by the CARES Act, the Company expects to defer the payment of payroll taxes each quarter for the remainder of 2020 to be paid in the fourth quarters of 2021 and 2022.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

A summary of the provision for income taxes and the corresponding effective tax rate for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2020 and 2019, ~~and September 30, 2018,~~ is shown ~~below (in thousands, except effective tax rates):~~

below:

													Three Months Ended
	Three Months Ended September 30,						Nine Months Ended September 30,						March 31,
	2019			2018			2019			2018			2020			2019
Income tax expense	$	6,771		$	3,688		$	19,214		$	9,807		$	5,406		$	6,895
Earnings before income tax	$	22,658		$	3,333		$	46,266		$	39,077		$	17,279		$	15,309
Effective tax rate		29.9	%		110.7	%		41.5	%		25.1	%		31.3	%		45.0	%

Income tax expense excluding impairment loss	$	6,771		$	3,688		$	19,214		$	9,807
Income tax expense													$	5,406		$	6,895
Earnings before income tax excluding impairment loss	$	23,495		$	14,809		$	67,472		$	50,553		$	17,279		$	25,793
Effective tax rate excluding impairment loss		28.8	%		24.9	%		28.5	%		19.4	%		31.3	%		26.7	%

For the ~~nine~~three months ended ~~September 30,~~March 31, 2019, the Company recognized a loss of ~~$21,206 related to an impairment loss for which no tax benefit was provided. Similarly, for the nine months ended September 30, 2018, the Company recognized a loss of $11,476~~$10,484 related to a non-deductible impairment loss. ~~Income tax expense, earnings before income tax and effective tax rate excluding the impairment loss are noted above.~~

The Company’s effective tax rate for the three months ended September 30, 2018 included a discrete benefit related to stock-based compensation. For the nine months ended September 30, 2018, the Company’s effective tax rate included a discrete benefit related to certain intercompany transactions which disproportionately benefited lower tax rate jurisdictions.

The annual effective tax rates differ from the U.S. statutory rate primarily due to foreign rates which differ from those in the U.S., U.S. taxes on foreign earnings, the realization of certain business tax credits, including research and development and foreign tax credits, and the applicable withholding taxes on the projected future repatriations of the earnings from the Company’s non-U.S. operations that are not considered permanently reinvested.

Note 9 – Details of Certain Balance Sheet Components

	March 31, 2020		December 31, 2019
Other current assets:
Income tax and other tax receivable	$	16,648	$	17,057
Notes receivable		9,308		9,963
Prepaid expenses		9,027		7,022
Billable tooling		5,471		5,194
Short-term derivative financial instruments		—		1,242
Other		4,487		2,248
Total other current assets	$	44,941	$	42,726
Other current liabilities:
Liabilities from discounts and rebates	$	18,877	$	16,593
Accrued employee liabilities		16,150		26,019
Restructuring		7,187		6,065
Income and other taxes payable		5,644		3,693
Derivative financial instruments		3,553		—
Accrued warranty		3,323		4,596
Other		12,266		9,617
Total other current liabilities	$	67,000	$	66,583

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

Note 10 – Goodwill and Other Intangibles

Goodwill

A summary of changes in the carrying amount of goodwill, by operating segment, for the ~~nine~~three months ended ~~September 30, 2019~~March 31, 2020 is as follows:

Nine Months Ended September 30, 2019

Automotive

Industrial

Total

Balance, beginning of period

$
37,533

$
17,778

$
55,311

Stihler acquisition

—

9,816

9,816

Currency impact

(1,388
)

(238
)

(1,626
)
Balance, end of period

$
36,145

$
27,356

$
63,501

	Automotive			Industrial			Total
Balance as of December 31, 2019	$	36,938		$	27,634		$	64,572
Exchange rate impact		(502	)		(176	)		(678	)
Balance as of March 31, 2020	$	36,436		$	27,458		$	63,894

Other Intangible Assets

Other intangible assets and accumulated amortization balances as of March 31, 2020 and December 31, 2019 were as follows:

	Gross Carrying Value		Accumulated Amortization			Net Carrying Value
Definite-lived:
Customer relationships	$	87,519	$	(51,181	)	$	36,338
Technology		27,782		(19,943	)		7,839
Product development costs		19,455		(18,240	)		1,215
Indefinite-lived:
Tradenames		4,670		—			4,670
Balance as of March 31, 2020	$	139,426	$	(89,364	)	$	50,062

	Gross Carrying Value		Accumulated Amortization			Net Carrying Value
Definite-lived:
Customer relationships	$	89,208	$	(50,687	)	$	38,521
Technology		25,106		(19,866	)		5,240
Product development costs		19,911		(18,559	)		1,352
Indefinite-lived:
Tradenames		4,670		—			4,670
Balance as of December 31, 2019	$	138,895	$	(89,112	)	$	49,783

On February 28, 2020, Gentherm acquired the automotive patents and technology of a development-stage technology company for $3,141. The investment was accounted for as an asset acquisition of defensive intangible assets and will be amortized over 6 years.

Note 11 – Debt

The following table summarizes the Company’s debt as of March 31, 2020 and December 31, 2019:

	March 31, 2020						December 31, 2019
	Interest Rate			Principal Balance			Interest Rate			Principal Balance
Amended Credit Agreement:
U.S. Revolving Note (U.S. Dollar Denominations)		2.20	%	$	183,000			3.05	%	$	50,000
U.S. Revolving Note (Euro Denominations)		1.25	%		42,417			1.25	%		21,874
DEG Vietnam Loan		5.21	%		8,750			5.21	%		8,750
Total debt					234,167						80,624
Less: current maturities					(2,500	)					(2,500	)
Long-term debt, less current maturities				$	231,667					$	78,124

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

Amended Credit Agreement

As of December 31, 2018, the Company, together with certain direct and indirect subsidiaries, had a credit agreement (the “Credit Agreement”) which included a revolving credit note (“U.S. Revolving Note”) with a maximum borrowing capacity of $350,000.

On June 27, 2019, the Company entered into an Amended and Restated Credit Agreement (the “Amended Credit Agreement”) with a consortium of lenders and Bank of America, N.A. as administrative agent. The Amended Credit Agreement ~~amends~~amended and ~~restates~~restated in its entirety the Credit Agreement. The outstanding principal and interest of the U.S. Revolving Note under the Credit Agreement continued and constitute obligations under the Amended Credit Agreement.

~~GENTHERM INCORPORATED~~

~~NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS~~

~~(In thousands, except share and per share data)~~

~~(Unaudited)~~

The Amended Credit Agreement increased the U.S. Revolving Note from $350,000 to $475,000 and extended the maturity from March 17, 2021 to June 27, 2024. Subject to specified conditions, the Company can increase the U.S. Revolving Note or incur secured term loans in an aggregate amount of $175,000. The Amended Credit Agreement also provides $15,000 availability for the issuance of letters of credit and a maximum of $40,000 for swing line borrowing. Any amount of the facility utilized for letters of credit or swing line loans outstanding will reduce the amount available under the Amended Credit Agreement. The Company had 0 outstanding letters of credit issued under the Amended Credit Agreement as of March 31, 2020 and December 31, 2019.

The U.S. borrowers and guarantors participating in the Amended Credit Agreement have entered into a related amended and restated pledge and security agreement. The amended and restated pledge and security agreement grants a security interest to the lenders in substantially all of the personal property of the Company and its U.S. subsidiaries designated as borrowers to secure their respective obligations under the Amended Credit Agreement, including the stock and membership interests of specified subsidiaries (limited to 66% of the stock in the case of certain non-U.S. subsidiaries). In addition to the security obligations, all obligations under the Amended Credit Agreement are unconditionally guaranteed by certain of the Company’s subsidiaries. The Amended Credit Agreement restricts, among other things, the amount of dividend payments the Company can make to shareholders.

The Amended Credit Agreement ~~requires~~contains covenants, that, among other things, (i) prohibit or limit the ~~Company~~ability of the borrowers and ~~its subsidiaries~~any material subsidiary to ~~comply~~incur additional indebtedness, create liens, pay dividends, make certain types of investments (including acquisitions), enter into certain types of transactions with ~~customary affirmative~~affiliates, prepay other indebtedness, sell assets, merge with other companies or enter into certain other transactions outside the ordinary course of business, and ~~negative covenants, and contain customary events of default. The Amended Credit Agreement also requires the Company to~~(ii) require that Gentherm maintain a minimum Consolidated Interest Coverage Ratio and Consolidated Leverage Ratio (based on consolidated EBITDA for the applicable trailing 12-month period as defined in the ~~agreement.~~Amended Credit Agreement) as of the end of any fiscal quarter. The Amended Credit Agreement also contains customary events of default.

Under the Amended Credit Agreement, U.S. Dollar denominated loans bear interest at either a base rate (“Base Rate Loans”) or Eurocurrency rate (“Eurocurrency Rate Loans”), plus a margin (“Applicable Rate”). The rate for Base Rate Loans is equal to the highest of the Federal Funds Rate ~~(1.90%~~(0.08% at ~~September 30, 2019)~~March 31, 2020) plus 0.50%, Bank of America’s prime rate ~~(5.00%~~(3.25% at ~~September 30, 2019)~~March 31, 2020), or the Eurocurrency rate ~~(0.00% at September 30, 2019)~~ plus 1.00%. The rate for Eurocurrency Rate Loans denominated in U.S. Dollars is equal to the London Interbank Offered Rate ~~(2.02%~~(0.99% at ~~September 30, 2019)~~March 31, 2020). All loans denominated in a currency other than the U.S. Dollar must be Eurocurrency Rate Loans. Interest is payable at least quarterly.

The Applicable Rate varies based on the Consolidated Leverage Ratio reported by the Company. As long as the Company is not in default of the terms and conditions of the Amended Credit Agreement, the lowest and highest possible Applicable Rate is 1.25% and 2.25%, respectively, for Eurocurrency Rate Loans and 0.25% and 1.25%, respectively, for Base Rate Loans.

In ~~connection with~~March 2020, the Company increased its borrowings under the Amended Credit Agreement by $169,546 as a safeguard to increase its cash position and provide additional financial flexibility due to the ~~Company incurred debt issuance costs of $1,278 which have been capitalized and~~COVID-19 pandemic. The proceeds will be ~~amortized into interest expense over~~used for working capital and for other general corporate purposes permitted by the ~~term~~Amended Credit Agreement. As of March 31, 2020, inclusive of the ~~credit facility.~~new borrowings, $225,417 was outstanding under the Amended Credit Agreement. Based upon consolidated EBITDA for the twelve months ended March 31, 2020, $226,743 remains available for additional borrowings under the Amended Credit Agreement subject to specified conditions that Gentherm currently satisfies.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

DEG Vietnam Loan

The Company also has ~~two~~a fixed interest rate ~~loans~~loan with the German Investment Corporation (“DEG”), a subsidiary of KfW Banking Group, a Germany government-owned development bank.

~~DEG China Loan~~

The first DEG loan, a loan we used to fund capital investments in China (the “DEG China Loan”), was subject to semi-annual principal payments that began March 2015 and ended in September 2019. During the third quarter of 2019, the DEG China Loan was paid in full.

~~DEG Vietnam Loan~~

~~The Company’s second~~ fixed interest rate senior loan agreement with DEG was used to finance the construction and set up of the Vietnam production facility (“DEG Vietnam Loan”). The DEG Vietnam Loan is subject to semi-annual principal payments that began November 2017 and will end May 2023. Under the terms of the DEG Vietnam Loan, the Company must maintain a minimum Equity Ratio and Enhanced Equity Ratio, as defined by the DEG Vietnam Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Vietnam Co. Ltd.

20As of March 31, 2020, the Company was in compliance with the terms of the Amended Credit Agreement and DEG Vietnam Loan.

The scheduled principal maturities of our debt as of March 31, 2020 were as follows:

Year	U.S. Revolving Note		DEG Vietnam Note		Total
Remainder of 2020	$	—	$	2,500	$	2,500
2021		—		2,500		2,500
2022		—		2,500		2,500
2023		—		1,250		1,250
2024		225,417		—		225,417
Total	$	225,417	$	8,750	$	234,167

Note 12 – Leases

The Company has operating leases for office, manufacturing and research and development facilities, as well as land leases for certain manufacturing facilities that are accounted for as operating leases. The Company also has operating leases for office equipment and automobiles. Excluding land leases, our leases have remaining lease terms ranging from less than 1 year to 12 years and may include options to extend the lease for an additional term equal to the original term of the lease. Land leases have remaining lease terms that range from 41 to 43 years and some which specify that the end of the lease term is at the discretion of the lessee. The Company does not have lease arrangements with related parties.

Components of lease expense for the three months ended March 31, 2020 were as follows:

	Three Months Ended
	March 31, 2020
Lease cost:
Operating lease cost	$	1,586
Short-term lease cost		509
Sublease income		(40	)
Total lease cost	$	2,055

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

~~Undrawn borrowing capacity under the U.S. Revolving Note was $385,129~~

Other information related to leases is as follows:

	Three Months Ended
	March 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	1,621
Right-of-use lease assets obtained in exchange for lease obligations:
Operating leases	$	6,349
	March 31, 2020
Weighted average remaining lease term:
Operating leases	6.5 years
Weighted average discount rate:
Operating leases		5.08	%

A summary of operating leases as of ~~September 30, 2019. The following table summarizes the Company’s debt as of September 30, 2019 and December~~March 31, ~~2018:~~

September 30,
2019

December 31,
2018

Interest
Rate

Principal
Balance

Principal
Balance

Amended Credit Agreement:

U.S. Revolving Note (U.S. Dollar Denominations)

3.29%

$
70,000

$
122,000

U.S. Revolving Note (Euro Denominations)

1.25%

19,623

5,727

DEG China Loan

—

—

913

DEG Vietnam Loan

5.21%

10,000

11,250

Total debt

99,623

139,890

Current portion

(2,500
)

(3,413
)
Long-term debt, less current maturities

$
97,123

$
136,477

~~The scheduled principal maturities of our debt as of September 30, 2019 are~~2020, under all non-cancellable operating leases with terms exceeding one year is as follows:

Year	U.S. Revolving Note		DEG Vietnam Note		Total
Remainder of 2019	$	—	$	1,250	$	1,250
2020		—		2,500		2,500
2020 (excluding the three months ended March 31, 2020)							$	4,252
2021		—		2,500		2,500		4,153
2022		—		2,500		2,500		1,997
2023		—		1,250		1,250		1,256
2024		89,623		—		89,623		1,258
2025 or later								5,468
Total future minimum lease payments								18,384
Less imputed interest								(2,780	)
Total	$	89,623	$	10,000	$	99,623	$	15,604

~~As of September 30, 2019, we were in compliance, in all material respects, with all terms as outlined in the Amended Credit Agreement and DEG Vietnam Loan.~~

Note 1213 – Financial Instruments

Cash, ~~cash equivalents~~Cash Equivalents and ~~restricted cash~~Restricted Cash

The Company has cash that is legally restricted as to use or withdrawal. A reconciliation of cash and cash equivalents on the consolidated condensed balance sheets to cash, cash equivalents and restricted cash presented on the consolidated condensed statements of cash flows is as follows:

	September 30, 2019		December 31, 2018		September 30, 2018		December 31, 2017		March 31, 2020		December 31, 2019
Cash and cash equivalents presented in the consolidated condensed balance sheets	$	45,200	$	39,620	$	47,152	$	103,172	$	222,939	$	50,443
Restricted cash		2,504		—		—		—		2,505		2,505
Cash, cash equivalents and restricted cash presented in the consolidated condensed statements of cash flows	$	47,704	$	39,620	$	47,152	$	103,172	$	225,444	$	52,948

~~GENTHERM INCORPORATED~~

~~NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS~~

~~(In thousands, except share and per share data)~~

~~(Unaudited)~~

Derivative Financial Instruments

~~We are~~The Company is exposed to various market ~~risk from~~risks including, but not limited to, changes in foreign currency exchange rates, ~~short-term~~changes in interest rates and commodity price ~~fluctuations of certain material commodities such as copper.~~fluctuations. Market risks for changes in interest rates relate primarily to ~~our~~its debt obligations under ~~our~~the Amended Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the ~~European~~ Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which ~~we hedge our~~the Company hedges its exposure to foreign currency exchange risks is one year. WeThe Company had foreign currency derivative contracts with a notional value of ~~$25,210~~$22,176 and ~~$33,250~~$14,449 outstanding as of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018,~~2019, respectively.

The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years. NaN commodity swap contracts were outstanding at September 30, 2019 or at December 31, 2018.

~~We do~~Company does not enter into derivative financial instruments for speculative or trading purposes. ~~Our~~The Company’s hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive loss in the consolidated condensed balance ~~sheet.~~sheets. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive loss is recorded in earnings in the consolidated condensed statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. ~~We record~~The Company records the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated condensed statements of income. See Note 14 for the amount of unrealized loss associated with foreign currency derivatives previously reported in accumulated other comprehensive loss that was reclassified into earnings during 2019. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term.

Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of ~~September 30,~~March 31, 2020 is as follows:

Asset Derivatives

Liability Derivatives

Hedge

Designation

Fair Value

Hierarchy

Balance Sheet

Location

Fair

Value

Balance Sheet

Location

Fair

Value

Net Asset/

(Liabilities)

Foreign currency derivatives

Cash flow hedge

Level 2

Other current assets

—

Other current liabilities

(3,553

)

(3,553

)

Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of December 31, 2019 is as follows:

Asset Derivatives

Liability Derivatives

Hedge
Designation

Fair Value
Hierarchy

Balance Sheet
Location

Fair
Value

Balance Sheet
Location

Fair
Value

Net Asset/
(Liabilities)

Foreign currency derivatives

Cash flow hedge

Level 2

Current assets

$
897

Current liabilities

$
—

$
897

Asset Derivatives

Liability Derivatives

Hedge

Designation

Fair Value

Hierarchy

Balance Sheet

Location

Fair

Value

Balance Sheet

Location

Fair

Value

Net Asset/

(Liabilities)

Foreign currency derivatives

Cash flow hedge

Level 2

Other current assets

1,242

Other current liabilities

—

1,242

Information relating to the effect of derivative instruments on our consolidated condensed statements of income is as follows:

														Three Months Ended March 31,
	Location	Three Months Ended September 30, 2019			Three Months Ended September 30, 2018		Nine Months Ended September 30, 2019			Nine Months Ended September 30, 2018			Location	2020			2019
Foreign currency derivatives	Cost of sales	$	328		$	391	$	1,003		$	(214	)	Cost of sales	$	78		$	240
	Selling, general and administrative		—			—		—			75		Other comprehensive (loss) income		(4,795	)		766
	Other comprehensive income		(257	)		1,753		806			2,304		Foreign currency loss		(71	)		(37	)
	Foreign currency gain (loss)		18			11		(51	)		58
Total foreign currency derivatives		$	89		$	2,155	$	1,758		$	2,223			$	(4,788	)	$	969
Commodity derivatives	Cost of sales	$	—		$	—	$	—		$	145
	Other comprehensive income		—			—		—		$	(218	)
Total commodity derivatives		$	—		$	—	$	—		$	(73	)

WeThe Company did 0t incur any hedge ineffectiveness during the three ~~and nine~~ months ended ~~September 30, 2019~~March 31, 2020 and ~~2018.~~2019.

2220

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

Note 1314 – Fair Value Measurements

~~The Company bases fair~~Fair value ~~on a~~is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants aton the measurement date. ~~We have adopted~~Fair value measurements are based on one or more of the following three valuation techniques:

Market: This approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

Income: This approach uses valuation techniques to convert future amounts to a single present value amount based on current market expectations.

Cost: This approach is based on the amount that would be required to replace the service capacity of an asset (replacement cost).

The Company uses the following fair value hierarchy ~~that prioritizes observable and unobservable inputs used~~ to measure fair value into three broad levels, which are described below:

Level 1:1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2:2: Inputs, other than quoted market prices included in Level 1, that are observable either directly or indirectly for the asset or liability.

Level 3:3: Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

Items Measured at Fair Value on a Recurring Basis

Except for derivative instruments (see Note 13), pension plan assets and a corporate owned life insurance policy, the Company had 0 material financial assets and liabilities that were carried at fair value at March 31, 2020 and December 31, 2019. In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value.

Items Measured at Fair Value on a ~~Recurring Basis~~

Except for derivative instruments (see Note 12) and the held for sale disposal group (see Note 4), the Company had 0 material financial assets and liabilities that are carried at fair value at September 30, 2019 and December 31, 2018. The carrying amounts of financial instruments comprising cash and cash equivalents, restricted cash, accounts receivable and accounts payable approximate their fair values due to the relatively short maturity of such instruments.

~~Items Measured at Fair Value on a~~ Nonrecurring Basis

The Company measures certain assets and liabilities at fair value on a non-recurring ~~basis, which are not included above. For further information related to assets and liabilities measured at~~basis. As these nonrecurring fair value ~~on a non-recurring basis, see Note~~measurements are generally determined using unobservable inputs, these fair value measurements are classified within Level 3 ~~"Acquisitions and Divestitures" and Note 4, “Assets and Liabilities Held for Sale”.~~

of the fair value hierarchy. As of ~~September 30,~~March 31, 2020 and December 31, 2019, there were 0 additional significant assets or liabilities measured at fair value on a non-recurring basis.

Items Not Carried at Fair Value

The Company uses an income valuation technique to measure the fair values of its debt instruments by converting amounts of future cash flows to a single present value amount using rates based on current market expectations (Level 2 inputs). As of ~~September 30, 2019,~~March 31, 2020, and December 31, ~~2018,~~2019, the carrying values of the indebtedness under the Company’s Amended Credit Agreement ~~and Credit Agreement, respectively,~~ were not materially different than ~~their~~its estimated fair values because the interest rates on variable rate debt approximated rates currently available to the Company (see Note 11). Discount rates used to measure the fair value of the DEG Vietnam Loan ~~and DEG China Loan~~ are based on quoted swap rates. As of ~~September 30, 2019, the carrying value and estimated fair value of the DEG Vietnam Loan were $10,000 and $10,213, respectively. As of December~~March 31, ~~2018,~~2020, the carrying value of the DEG Vietnam Loan ~~and DEG China Loan were $11,250 and $913, respectively,~~was $8,750 as compared to an estimated fair value of ~~$11,100 and $900, respectively.~~$9,063. As of December 31, 2019, the carrying value of the DEG Vietnam Loan was $8,750 as compared to an estimated fair value of $8,785.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

Note 1415 – Equity

In December 2016, the Board of Directors of Gentherm Incorporated (“Board of Directors”) authorized a three-year, $100 million stock repurchase program (“Stock Repurchase Program”). In June 2018, the Board of Directors authorized an increase and extension of the Stock Repurchase Program to $300 million, and extended the Stock Repurchase Program until December 2020. In March 2020, the Company suspended its Share Repurchase Program in order to preserve liquidity. However, repurchases under the Stock Repurchase Program may resume at management’s discretion and may be made, from time to time, in amounts and at prices the Company deems appropriate, subject to market conditions, applicable legal requirements, debt covenants and other considerations. Any such repurchases may be executed using open market purchases, privately negotiated agreements or other transactions. Repurchases under the Stock Repurchase Program may be funded from cash on hand, available borrowings or proceeds from potential debt or other capital markets sources. During the three months ended March 31, 2020, the Company repurchased approximately $9.1 million of shares with an average price paid per share of $36.93 and have a remaining repurchase authorization of approximately $74.2 million.

Note 16 – Reclassifications Out of Accumulated Other Comprehensive ~~Income (Loss)~~Loss

Reclassification adjustments and other activities impacting accumulated other comprehensive income (loss) during the three ~~and nine~~ months ended ~~September 30,~~March 31, 2020 and March 31, 2019 ~~and 2018 are~~were as follows:

	Defined Benefit Pension Plans			Foreign Currency Translation Adjustments			Foreign Currency Hedge Derivatives				Total
Balance at December 31, 2019	$	(3,371	)	$	(39,965	)	$	895			$	(42,441	)
Other comprehensive loss before reclassifications		—			(8,687	)		(4,170	)			(12,857	)
Income tax effect of other comprehensive (loss) income before reclassifications		—			(53	)		909				856
Amounts reclassified from accumulated other comprehensive loss into net income		—			—			(625	)	a		(625	)
Income taxes reclassified into net income		—			—			136				136
Net current period other comprehensive loss		—			(8,740	)		(3,750	)			(12,490	)
Balance at March 31, 2020	$	(3,371	)	$	(48,705	)	$	(2,855	)		$	(54,931	)

Defined
Benefit
Pension
Plans

Foreign
Currency
Translation
Adjustments

Foreign
Currency
Hedge
Derivatives

Total

Balance at June 30, 2019

$
(2,339
)

$
(37,928
)

$
827

$
(39,440
)
Other comprehensive income (loss) before reclassifications

—

(14,857
)

167

(14,690
)
Income tax effect of other comprehensive income (loss)
before reclassifications

—

(315
)

(36
)

(351
)
Amounts reclassified from accumulated other
comprehensive income (loss) into net income (loss)

—

—

(424
)
a

(424
)
Income taxes reclassified into net income (loss)

—

—

91

91

Net current period other comprehensive income (loss)

—

(15,172
)

(202
)

(15,374
)
Balance at September 30, 2019

$
(2,339
)

$
(53,100
)

$
625

$
(54,814
)

(a)

The amounts reclassified from accumulated other comprehensive income (loss) were included in cost of sales.

	Defined Benefit Pension Plans			Foreign Currency Translation Adjustments			Foreign Currency Hedge Derivatives				Total
Balance at December 31, 2018	$	(2,339	)	$	(37,157	)	$	(4	)		$	(39,500	)
Other comprehensive income (loss) before reclassifications		—			(4,074	)		717				(3,357	)
Income tax effect of other comprehensive loss before reclassifications		—			(177	)		(156	)			(333	)
Amounts reclassified from accumulated other comprehensive loss into net income		—			—			49		a		49
Income taxes reclassified into net income		—			—			(11	)			(11	)
Net current period other comprehensive (loss) income		—			(4,251	)		599				(3,652	)
Balance at March 31, 2019	$	(2,339	)	$	(41,408	)	$	595			$	(43,152	)

(a)	The amounts reclassified from accumulated other comprehensive income (loss) ~~are~~were included in cost of sales.

The Company expects all of the existing gains and losses related to foreign currency hedge derivatives reported in accumulated other comprehensive loss as of March 31, 2020 to be reclassified into earnings during the next twelve months. See Note 13 for additional information about derivative financial instruments and the effects from reclassification to net income.

Defined
Benefit
Pension
Plans

Foreign
Currency
Translation
Adjustments

Foreign
Currency
Hedge
Derivatives

Total

Balance at June 30, 2018

$
(2,406
)

$
(29,040
)

$
(397
)

$
(31,843
)
Other comprehensive income (loss) before reclassifications

—

(3,266
)

1,586

(1,680
)
Income tax effect of other comprehensive income (loss)
before reclassifications

—

15

(491
)

(476
)
Amounts reclassified from accumulated other
comprehensive income (loss) into net income (loss)

—

—

167

a

167

Income taxes reclassified into net income (loss)

—

—

(45
)

(45
)
Net current period other comprehensive income (loss)

—

(3,251
)

1,217

(2,034
)
Balance at September 30, 2018

$
(2,406
)

$
(32,291
)

$
820

$
(33,877
)

~~(a)~~

~~The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.~~

Defined
Benefit
Pension
Plans

Foreign
Currency
Translation
Adjustments

Foreign
Currency
Hedge
Derivatives

Total

Balance at December 31, 2018

$
(2,339
)

$
(37,157
)

$
(4
)

$
(39,500
)
Other comprehensive income (loss) before reclassifications

—

(15,454
)

1,359

(14,095
)
Income tax effect of other comprehensive income (loss)
before reclassifications

—

(489
)

(296
)

(785
)
Amounts reclassified from accumulated other
comprehensive income (loss) into net income (loss)

—

—

(553
)
a

(553
)
Income taxes reclassified into net income (loss)

—

—

119

119

Net current period other comprehensive income (loss)

—

(15,943
)

629

(15,314
)
Balance at September 30, 2019

$
(2,339
)

$
(53,100
)

$
625

$
(54,814
)

~~(a)~~

~~The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.~~

2422

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except percentages, share and per share data)

(Unaudited)

Note 17 – Commitments and Contingencies

Defined
Benefit
Pension
Plans

Foreign
Currency
Translation
Adjustments

Commodity
Hedge
Derivatives

Foreign
Currency
Hedge
Derivatives

Total

Balance at December 31, 2017

$
(2,366
)

$
(17,555
)

$
277

$
(800
)

$
(20,444
)
Cumulative effect of accounting change due to
   adoption of ASU 2018-02

(40
)

—

—

—

(40
)
Other comprehensive income (loss) before
   reclassifications

—

(14,519
)

—

2,048

(12,471
)
Income tax effect of other comprehensive income
   (loss) before reclassifications

—

(217
)

—

(615
)

(832
)
Amounts reclassified from accumulated other
   comprehensive income (loss) into net income (loss)

—

—

(218
)
a

256

a

38

Income taxes reclassified into net income (loss)

—

—

(59
)

(69
)

(128
)
Net current period other comprehensive income
   (loss)

(40
)

(14,736
)

(277
)

1,620

(13,433
)
Balance at September 30, 2018

$
(2,406
)

$
(32,291
)

$
—

$
820

$
(33,877
)

~~(a)~~

~~The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.~~

~~We expect all~~The Company may be subject to various legal actions and claims in the ordinary course of its business, including those arising out of breach of contracts, product warranties, product liability, intellectual property rights, environmental matters, regulatory matters and employment-related matters. The Company establishes accruals for matters which it believes that losses are probable and can be reasonably estimated. Although it is not possible to predict with certainty the outcome of these matters, the Company is of the ~~existing gains~~opinion that the ultimate resolution of these matters will not have a material adverse effect on its consolidated condensed results of operations or financial position. Product liability and ~~losses related~~warranty reserves are recorded separately from legal reserves, as described below.

Product Liability and Warranty Matters

The Company accrues warranty obligations for products sold based on management estimates of future failure rates and current claim cost experience, with support from the sales, engineering, quality and legal functions. Using historical information available to ~~foreign currency derivatives reported~~the Company, including claims already filed by customers, the warranty accrual is adjusted quarterly to reflect management’s best estimate of future claims. The Company maintains liability insurance coverage at levels based on commercial norms and historical claims experience. The Company can provide no assurances that it will not experience material claims in ~~accumulated other comprehensive loss as~~the future or that it will not incur significant costs to defend such claims.

The following is a reconciliation of ~~September 30, 2019 to be reclassified into earnings during~~ the ~~next twelve months. See Note 12 for additional information about derivative financial instruments and the effects from reclassification to net income (loss).~~changes in accrued warranty costs:

	Three Months Ended
	March 31,
	2020			2019
Balance at beginning of the period	$	4,596		$	4,514
Warranty claims paid		(1,278	)		(276	)
Warranty expense for products shipped during the period		500			709
Adjustments to warranty estimates from prior periods		(450	)		(305	)
Adjustments due to currency translation		(45	)		(26	)
Balance at end of period	$	3,323		$	4,616

Note 1518 – ~~Leases~~Subsequent Events

~~The~~Subsequent to March 31, 2020, the impact of the COVID-19 pandemic on our business, results of operations and financial condition has materially worsened as compared to the first quarter of 2020. In particular, the Company ~~has operating leases for office,~~significantly reduced production at its manufacturing facilities in response to COVID-19 related government mandates, reduced demand conditions and ~~research~~other operational drivers. This resulted in temporary, partial closures of several of the Company’s manufacturing facilities in the North America and ~~development facilities, as well as land leases for~~Europe. Meanwhile, certain manufacturing facilities that ~~are accounted for~~were closed as ~~operating leases. We also~~of March 31, 2020 have operating leases for office equipment and automobiles. Excluding land leases, our leases have remaining lease terms ranging from less than 1 year to 7 years and may include options to extend the lease for an additional term equal to the original termre-opened. The extent of the ~~lease. Land leases have remaining lease terms that range from 41 to 44 years and some which specify that the end~~further impact of the ~~lease term is at the discretion of the lessee. We do not have lease arrangements with related parties.~~

~~Accounting Policy~~

The Company determines whether a contractual arrangement is or contains a lease at inception. Leases that are operating in nature are recognized in operating lease right-of-use assets, current lease liabilities and non-current lease liabilities on our consolidated condensed balance sheets. While Gentherm is not currently party to any leases that qualify as financing leases, right-of-use assets and liabilities recognized from financing leases would be presented separately from the right-of-use assets and liabilities recognized from operating leases on our consolidated condensed balance sheet.

Lease liabilities are measured initially at the present value of the sum of the future minimum rental payments at the commencement date of the lease. Lease payments that will vary in the future due to changes in facts and circumstances are excluded from the calculation of rental payments, unless those variable payments are based on an index or rate. Rental payments are discounted using an incremental borrowing rate basedCOVID-19 outbreak on the Company’s ~~credit rating, determined~~operational and financial performance, even after business operations resume, will depend on ~~a fully collateralized loan basis from information available at commencement date,~~certain developments, including the duration and spread of the outbreak, the impact on its customers and suppliers and the ~~duration~~range of the lease term (the “reference rate”). Judgement is used to assess the importance of risk factor inputs during the computation of the Company’s credit rating. For significant leases at foreign subsidiaries denominated in U.S. Dollars, a risk premium associated with the borrower subsidiary’s country is addedgovernmental and community reactions to the ~~reference rate. For significant leases~~pandemic, which are uncertain and cannot be fully predicted at foreign subsidiaries denominated in a foreign currency, the U.S. Dollar risk free rate with a duration similar to that of the lease term is subtracted from the reference rate and a corresponding foreign currency risk free rate with a duration similar to that of the lease term is added to the reference rate. Judgement is used to determine whether foreign subsidiary leases are significant.

~~GENTHERM INCORPORATED~~

~~NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS~~

~~(In thousands, except share and per share data)~~

~~(Unaudited)~~this time.

Operating lease right-of-use assets are measured at the amount of the lease liability, adjusted for prepaid or accrued lease payments, lease incentive received, and initial direct costs incurred, as applicable. Periods covered by an option to extend the lease are initially included in the measurement of an operating lease right-of-use asset and lease liability only when it is reasonably certain we will exercise the option. Gentherm’s lease agreements do not contain residual value guarantees or impose restrictions or covenants on the Company.

For all classes of underlying assets, the Company accounts for leases that contain separate lease and nonlease components as containing a single lease component. The Company does not recognize lease right-of-use assets and lease liabilities from leases with an original lease term of 12 months or less and, instead, recognizes rent payments on a straight-line basis over the lease term in the Company’s consolidated condensed statements of income (loss). See Note 2 to our consolidated condensed financial statements for description of the impacts that resulted from the adoption of a new lease standard.

~~Components of lease expense for the nine months ended September 30, 2019 are as follows:~~

Lease cost:

Operating lease cost

$
4,477

Short-term lease cost

2,678

Sublease income

(91
)
Total lease cost

$
7,064

~~Weighted-average remaining lease term and discount rate is as follows:~~

~~Weighted Average Remaining Lease Term:~~
~~Operating leases~~	~~4.6~~
~~Weighted Average Discount Rate:~~
~~Operating leases~~	~~5.45~~	%

~~Other information:~~

Supplemental Cash Flow Information:

Gain on sale and leaseback transactions, net

$
207

Cash paid for amounts included in the measurement of lease
liabilities:

Operating cash flows from operating leases

$
4,539

Right-of-use lease assets obtained in exchange for lease
obligations:

Operating leases

$
3,339

~~A summary of operating leases as of September 30, 2019, under all non-cancellable operating leases with terms exceeding one year is as follows:~~

2019 (excluding the nine months ended September 30, 2019)

$
1,393

2020

4,570

2021

2,674

2022

1,550

2023

790

2024 or later

2,600

Total future minimum lease payments

$
13,577

Less imputed interest

(1,703
)
Total

$
11,874

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our goals, beliefs, plans and expectations about our prospects for the future and other future events, such as the impact of the COVID-19 pandemic on our ~~ability to execute our strategic plan~~financial results, liquidity, and ~~Manufacturing Footprint Rationalization restructuring plan, our ability to finance sufficient working capital,~~business as well as the global economy, the amount of borrowing availability under the Amended Credit Agreement ~~and other indebtedness, our ability to continue to maintain or increase sales and profits of our operations,~~ and the sufficiency of our cash balances and cash generated from operating, investing and financing activities for our future liquidity and capital resource ~~needs.~~needs, our ability to finance sufficient working capital, our ability to execute our strategic plan and Manufacturing Footprint Rationalization restructuring plan. Reference is made in particular to forward-looking statements included in this “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of ~~Operations.~~Operations”. Such statements may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “anticipate”, “intend”, “continue”, or similar terms, variations of such terms or the negative of such terms. The forward-looking statements included in this Report are made as of the date hereof or as of the date specified herein and are based on management’s current expectations and beliefs. Such statements are subject to a number of assumptions, risks, uncertainties and other factors, which are set forth in “Item 1A. Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, ~~2018,~~2019, Part II “Item 1A. Risk Factors” in this Report and subsequent reports filed with the Securities and Exchange Commission, and which could cause actual results to differ materially from that described in the forward-looking statements. In addition, such forward-looking statements do not include the potential impact of any business combinations, acquisitions, divestitures, strategic investments and other significant transactions that may be completed after the date hereof, each of which may present material risks to the Company’s business and financial results. Except as required by law, we expressly disclaim any obligation or undertaking to update any forward-looking statements to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our consolidated condensed financial statements and related notes thereto included elsewhere in this Report and our consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, ~~2018.~~2019.

Overview

Gentherm Incorporated is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Unless the context otherwise requires, the terms “Gentherm”, “Company”, “we”, “us” and “our” used herein refer to Gentherm Incorporated and its consolidated subsidiaries. Our products provide solutions for automotive passenger climate comfort and convenience, battery thermal management and cell connecting systems, as well as patient temperature management within the health care industry. Our automotive products can be found onin the vehicles of nearly all major automotive manufacturers operating in North America and Europe, and several major automotive manufacturers in Asia. We operate in locations aligned with our major customers’ product strategies to provide locally enhanced design, integration and production ~~capabilities and to identify future thermal technology product opportunities in both automotive and other markets.~~capabilities. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets.

Our sales are driven by the number of vehicles produced by the automotive ~~products are sold~~manufacturers, which is ultimately dependent on consumer demand for automotive vehicles, and our content per vehicle. Historically, new vehicle demand has been driven by macro-economic and other factors, such as interest rates, manufacturer and dealer sales incentives, fuel prices, consumer confidence, employment levels, income growth trends and government and tax incentives. Economic volatility or weakness, as well as geopolitical factors, in North America, Europe or Asia, could result in a significant reduction in automotive sales and production by our customers, which would have an adverse effect on our business, results of operations and financial condition. While our diversified automotive OEM customer base and geographic revenue base, along with our flexible cost structure, have well positioned us to ~~automobile~~withstand the impact of industry downturns, including the current impact of the COVID-19 pandemic, and benefit from industry upturns in the ordinary course, shifts in the mix of global automotive production to higher cost regions or to vehicles with less content could adversely impact our profitability. In addition, we may be adversely impacted by volatility, weakness or slow growth in markets for hybrid electric vehicles specifically.

Recent Trends and Economic Conditions

The COVID-19 pandemic has significantly disrupted global economic activity, including in the automotive market. As a result of the global spread of the COVID-19 pandemic, light vehicle production volumes have declined across all regions. According to the forecasting firm IHS Markit, global light vehicle production was 17.6 million units in the first quarter of 2020, down from 22.9 million units in the first quarter of 2019, a decline of 23.0%. In the first quarter of 2020, customer plants in North America and Europe were closed beginning in the second half of March due to the pandemic. This resulted in temporary, partial closures of several of our manufacturing facilities in the North America and Europe by the end of March. In Asia, customer plants, as well as our plants, were closed for several weeks in February, and operated at reduced volumes in March. The impact of the outbreak has expanded beyond China and its surrounding regions where the outbreak initially began in December 2019 and has transitioned to an event impacting the entire global economy and automotive market. IHS Markit forecasted light vehicle production volumes for full-year 2020 is 69.3 million units, a decline of 22.0% from full-year 2019.

With respect to our key markets, actual light vehicle production volumes in North America for the first quarter of 2020 were 3.8 million units compared to 4.2 million units in the first quarter of 2019, a decrease of 9.5%, and light ~~truck OEMs~~vehicle production volumes in Europe were 4.6 million units for the first quarter of 2020 compared to 5.7 million units in the first quarter of 2019, a decrease of 19.3%. Actual light vehicle production volumes in Japan/Korea were 3.0 million units in the first quarter of 2020 compared to 3.3 million units in the first quarter of 2019, a decrease of 9.1%. The largest light vehicle production volume decline was in China, with 3.2 million units in the first quarter of 2020 compared to 6.0 million units in the first quarter of 2019, a decrease of 46.7%.

While the COVID-19 pandemic materially adversely affected our results of operations in the first quarter, the full extent of the impact may not be fully reflected in our results of operations until future periods, and we believe that the adverse impact of the COVID-19 pandemic has worsened in the second quarter. Such impact will be materially adverse to our business and results of operations, and may be materially adverse to our financial condition, cash flows, liquidity and stock price. In light of the substantial economic and financial impact of the COVID-19 pandemic and resulting uncertainties, the Company has taken significant actions to address its liquidity position. In March 2020, the Company borrowed an additional $169 million under its revolving credit facility to increase its cash position and provide additional financial flexibility. In addition, the Company has been prudently addressing its day-to-day operations, including reducing expenses, inventory levels and capital spending and deferring 2020 base salaries generally for salaried employees. See “—Liquidity and Capital Resources” below for additional information.

New Business Awards

We believe that innovation is an important element to gaining market acceptance of our products and strengthening our market position. During the first quarter of 2020, we secured an estimated $120 million of automotive new business awards, which represents the estimated future lifetime product revenues for all automotive customers. Automotive new business awards represent the aggregate projected lifetime revenue of new awards provided by customers to Gentherm in the applicable period, with the value based on the price and volume projections received from each customer as of the award date. Although automotive new business awards are not firm customer orders, we believe that new business awards are an indicator of future revenue. New business awards are not projections of revenue or ~~their tier one suppliers. Inherent~~future business as of March 31, 2020, the date of this Report or any other date. Customer projections regularly change over time and we do not update our calculation of any new business award after the date initially communicated. Automotive new business awards in the first quarter 2020 also do not reflect, in particular, the impact of the COVID-19 pandemic on future business. Revenues resulting from automotive new business awards also are subject to additional risks and uncertainties as described under “Forward-Looking Statements” above.

Divestitures

Divestiture of CSZ-IC

On February 1, 2019, the Company completed the divestiture of CSZ-IC and the former Cincinnati Sub-Zero headquarters facility to Weiss Technik North America, Inc. for total cash proceeds of $47.5 million. In connection with the sale, Gentherm entered into an operating lease agreement for a portion of the office and manufacturing building space purchased by Weiss Technik North America, Inc. The Company recognized a $5.0 million pre-tax gain on the sale of CSZ-IC during the three months ended March 31, 2019. $2.5 million of cash proceeds remain in an escrow account pending resolution of a claim.

Divestiture of GPT

On October 1, 2019, the Company completed the divesture of GPT for a nominal amount.

Acquisitions

Acquisition of Stihler Electronic GmbH (“Stihler”)

On April 1, 2019, Gentherm acquired Stihler, a leading developer and manufacturer of patient and blood temperature management systems, for a purchase price of $15.5 million, net of cash acquired and including $0.7 million of contingent consideration to be paid upon achievement of a milestone that must be completed by September 2020. In addition, the purchase agreement includes a contingent payment of $0.7 million to be paid if the selling shareholder remains employed by Stihler through December 2020, which will be recorded as a component of selling, general and administrative expenses ratably over the service period. The results of operations of Stihler are reported within the Company’s Industrial segment from the date of acquisition.

Restructuring

Manufacturing Footprint Rationalization

On September 23, 2019, the Company committed to a restructuring plan to improve the Company’s manufacturing productivity and rationalize its footprint. Under this plan, the Company will relocate and consolidate certain existing automotive manufacturing and, as a result, reduce the number of plants by two. During the three months ended March 31, 2020, the Company recognized expense of $0.2 million for employee separation costs that will be paid pursuant to the ~~automotive supplier market are~~terms of statutory requirements of the affected locations. Additionally, the Company recognized $0.2 million of accelerated depreciation during such period. The Company has recorded approximately $7.4 million of restructuring expenses since the inception of this program.

See Note 4, “Restructuring”, to our consolidated condensed financial statements included in this Report for information about our restructuring activities.

GPT and CSZ-IC Restructuring

During 2019, the Company completed its plan to eliminate non-core areas of investment through the divestitures of its environmental test equipment business, Cincinnati Sub-Zero industrial chamber business (“CSZ-IC”) and its remote power generation systems business, Gentherm Global Power Technologies (“GPT”). In addition, we launched a plan to optimize our manufacturing footprint and took additional actions to reduce costs through purchasing excellence and additional restructuring activities focused on reductions of selling, general and administrative expense. During the three months ended March 31, 2019, the Company recognized $0.3 million of employee separation costs, and ~~commitments that are incurred well~~$0.8 million of other related costs, related to the marketing of GPT and CSZ-IC, in ~~advance~~restructuring expenses.

See Note 4, “Restructuring”, to our consolidated condensed financial statements included in this Report for information about our restructuring activities.

Other Restructuring Activities

As part of the ~~receipt~~Company’s continued efforts to optimize its cost structure, the Company has undertaken several discrete restructuring actions. During the three months ended March 31, 2020 and 2019, the Company recognized $3.1 million and $0.4 million of ~~orders~~employee separation costs, respectively, and ~~resulting revenues~~$0.2 million and less than $0.1 million of other related costs, respectively. In addition, during the three months ended March 31, 2019, the Company recognized $0.4 million of asset impairment loss. These restructuring expenses were primarily associated with restructuring actions focused on the rotation of our manufacturing footprint to lower cost locations and the reduction of global overhead costs. These discrete restructuring actions are expected to approximate the total cumulative costs for those actions. The Company will continue to explore opportunities to improve its future profitability and competitiveness. These actions may result in the recognition of additional restructuring charges that could be material

See Note 4, “Restructuring”, to our consolidated condensed financial statements included in this Report for information about our restructuring activities.

Stock Repurchase Program

In December 2016, the Board of Directors authorized a three-year, $100.0 million stock repurchase program. In June 2018, our Board of Directors authorized an increase in the stock repurchase program to $300.0 million and extended the stock repurchase program until December 2020. In March 2020, the Company suspended its share repurchase program in order to preserve liquidity. However, repurchases under the stock repurchase program may resume at management’s discretion and may be made, from ~~customers. This is due~~time to time, in ~~part~~amounts and at prices the Company deems appropriate, subject to ~~automotive manufacturers requiring~~market conditions, applicable legal requirements, debt covenants and other considerations. During the ~~design, coordination~~three months ended March 31, 2020, we repurchased approximately $9.1 million of shares and ~~testing~~have a remaining repurchase authorization of ~~proposed new components and sub-systems. Revenues from these expenditures are typically not realized~~approximately $74.2 million.

See Note 15, “Equity”, to our consolidated condensed financial statements included in this Report for ~~two to three years due to this development cycle.~~information about our stock repurchase program.

Reportable Segments

The Company has two reportable segments for financial reporting purposes: Automotive and Industrial. See Note 76, “Segment Reporting”, to the consolidated condensed financial statements included in this Report for a description of our reportable segments as well as their proportional contribution to the Company’s reported product revenues and operating income. The financial information used by our chief operating decision maker to assess operating performance and allocate resources is based on these reportable segments.

Results of Operations First Quarter 2020 Compared with First Quarter 2019

The results of operations for the three months ended March 31, 2020 and March 31, 2019, in thousands, were as follows:

	Three Months Ended
	March 31,
	2020			2019			Favorable / (Unfavorable)
Product revenues	$	228,613		$	257,921		$	(29,308	)
Cost of sales		162,546			182,614			20,068
Gross margin		66,067			75,307			(9,240	)
Operating expenses:
Net research and development expenses		17,760			18,897			1,137
Selling, general and administrative expenses		25,840			32,651			6,811
Restructuring expenses		3,766			1,914			(1,852	)
Total operating expenses		47,366			53,462			6,096
Operating income		18,701			21,845			(3,144	)
Interest expense, net		(748	)		(1,368	)		620
Foreign currency (loss) gain		(938	)		203			(1,141	)
Gain on sale of business		—			4,970			(4,970	)
Impairment loss		—			(10,484	)		10,484
Other income		264			143			121
Earnings before income tax		17,279			15,309			1,970
Income tax expense		5,406			6,895			1,489
Net income	$	11,873		$	8,414		$	3,459

Product revenues by product category, in thousands, for the three months ended March 31, 2020 and March 30, 2019, were as follows:

	Three Months Ended
	March 31,
	2020		2019		% Change
Climate Control Seats (CCS)	$	82,528	$	94,354		(12.5	%)
Seat Heaters		64,532		73,920		(12.7	%)
Automotive Cables		22,140		23,749		(6.8	%)
Steering Wheel Heaters		19,235		16,970		13.3	%
Battery Thermal Management (BTM)		11,209		10,745		4.3	%
Electronics		10,376		12,852		(19.3	%)
Other Automotive		6,452		9,767		(33.9	%)
Subtotal Automotive	$	216,472	$	242,357		(10.7	%)
Medical		12,141		8,187		48.3	%
GPT		—		3,959		(100.0	%)
CSZ-IC		—		3,418		(100.0	%)
Subtotal Industrial	$	12,141	$	15,564		(22.0	%)
Total Company	$	228,613	$	257,921		(11.4	%)

Product Revenues

Below is a summary of our product revenues, in thousands, for the three months ended March 31, 2020 and March 31, 2019:

Three Months Ended March 31,

Variance Due To:

2020

2019

Favorable /

(Unfavorable)

Volume

Pricing/Other

Total

Product revenues

228,613

257,921

(29,308

)

(17,193

)

(3,149

)

(8,966

)

(29,308

)

Product revenues for the three months ended March 31, 2020 decreased 11.4% as compared to the three months ended March 31, 2019. The decrease in product revenues is primarily due to unfavorable volumes in our Automotive segment, with an estimated $28 million of such decrease driven by the COVID-19 pandemic. Product revenues were also negatively impacted by foreign currency impacts, primarily related to the Euro, Korean Won and Chinese Renminbi. The decrease in product revenues included in Variance Due To Pricing/Other above is primarily attributable to the divestitures of CSZ-IC on February 1, 2019 and GPT on October 1, 2019, as well as decreases in customer pricing, partially offset by the acquisition of Stihler on April 1, 2019. The decrease in product revenues included in Variance Due To Pricing/Other above was also offset by an increase in product revenue of approximately $1 million in our Industrial segment primarily due to increased demand for our Blanketrol® solutions to support temperature management of COVID-19 patients.

Cost of Sales

Below is a summary of our cost of sales and gross margin, in thousands, for the three months ended March 31, 2020 and March 31, 2019:

	Three Months Ended March 31,									Variance Due To:
	2020			2019			Favorable / (Unfavorable)			Volume			Operational Performance		FX			Other			Total
Cost of sales	$	162,546		$	182,614		$	20,068		$	9,726		$	6,164	$	1,754		$	2,424		$	20,068
Gross margin		66,067			75,307			(9,240	)	$	(7,467	)	$	684	$	(1,395	)	$	(1,062	)	$	(9,240	)
Gross margin - Percentage of product revenues		28.9	%		29.2	%

Cost of sales for the three months ended March 31, 2020 decreased 11.0% as compared to the three months ended March 31, 2019. The decrease in cost of sales is due to the volume decreases of $17.6 million for our Automotive segment primarily related to the impact of the COVID-19 pandemic, operational performance improvements and favorable foreign currency impacts, primarily attributable to the Euro, Mexican Peso, Ukrainian Hryvnia and Chinese Renminbi. The operational performance improvements are primarily attributable to decrease in material costs. The decrease in cost of sales is also due to the following items included in Variance Due to Other above:

•

$5.2 million of decrease attributable to divested businesses (CSZ-IC and GPT);

•

$1.2 million of increase due to higher labor costs in Mexico, Ukraine and Macedonia, partially offset by lower labor costs in China; and

•

$2.0 million of increase attributable to Medical, including the impact of the acquisition of Stihler on April 1, 2019.

Net Research and Development Expenses

Below is a summary of our net research and development expenses, in thousands, for the three months ended March 31, 2020 and March 31, 2019:

	Three Months Ended March 31,
	2020			2019			Favorable / (Unfavorable)
Research and development expenses	$	20,537		$	22,608		$	2,071
Reimbursed research and development expenses	$	(2,777	)	$	(3,711	)	$	(934	)
Net research and development expenses	$	17,760		$	18,897		$	1,137
Percentage of product revenues		7.8	%		7.3	%

Net research and development expenses for the three months ended March 31, 2020 decreased 6.0% as compared to the three months ended March 31, 2019. The decrease in net research and development expenses is primarily related to reduced project-related spending.

Selling, General and Administrative Expenses

Below is a summary of our selling, general and administrative expenses, in thousands, for the three months ended March 31, 2020 and March 31, 2019:

	Three Months Ended March 31,
	2020			2019			Favorable / (Unfavorable)
Selling, general and administrative expenses	$	25,840		$	32,651		$	6,811
Percentage of product revenues		11.3	%		12.7	%

Selling, general and administrative expenses for the three months ended March 31, 2020 decreased 20.9% as compared to the three months ended March 31, 2019. The decrease in selling, general and administrative expenses is primarily related to the impacts of divested businesses (CSZ-IC and GPT), lower stock compensation expense as a result of mark to market revaluation of stock appreciation rights during the three months ended March 31, 2020, as well as the absence of CFO transition costs in the three months ended March 31, 2020.

Restructuring Expenses

Below is a summary of our restructuring expenses, in thousands, for the three months ended March 31, 2020 and March 31, 2019:

Three Months Ended March 31,

2020

2019

Favorable /

(Unfavorable)

Restructuring expenses

3,766

1,914

(1,852

)

Restructuring expenses primarily relate to the Manufacturing Footprint Rationalization restructuring program and other discrete restructuring actions focused on the rotation of our manufacturing footprint to lower cost locations and the reduction of global overhead expenses. During the three months ended March 31, 2020, the Company recognized expenses of $3.3 million for employee separation costs, $0.2 million of accelerated depreciation and $0.2 million of other related costs. During the three months ended March 31, 2019, the Company recognized expenses of $0.6 million for employee separation costs, $0.4 million of asset impairment charges and $0.8 million of other related costs.

See Note 4, “Restructuring” of the consolidated condensed financial statements included in this Report for additional information.

Interest Expense

Below is a summary of our interest expense, in thousands, for the three months ended March 31, 2020 and March 31, 2019:

Three Months Ended March 31,

2020

2019

Favorable /

(Unfavorable)

Interest expense, net

(748

)

(1,368

)

620

See Note 11, “Debt” of the consolidated condensed financial statements included in this Report for additional information.

Foreign Currency (Loss) Gain

Below is a summary of our foreign currency (loss) gain, in thousands, for the three months ended March 31, 2020 and March 31, 2019:

Three Months Ended March 31,

2020

2019

Favorable /

(Unfavorable)

Foreign currency (loss) gain

(938

)

203

(1,141

)

Foreign currency loss for the three months ended March 31, 2020 included net realized foreign currency loss of $0.2 million and net unrealized foreign currency loss of $0.8 million.

Foreign currency gain for the three months ended March 31, 2019 included net realized foreign currency loss of $0.8 million and net unrealized foreign currency gain of $1.0 million.

Gain on Sale of ~~Cincinnati Sub-Zero Industrial Chamber~~ Business ~~(CSZ-IC)~~

Below is a summary of our gain on sale of business, in thousands, for the three months ended March 31, 2020 and March 31, 2019:

Three Months Ended March 31,

2020

2019

Favorable /

(Unfavorable)

Gain on sale of business

—

4,970

(4,970

)

On February 1, 2019, as part of the Company’s Fit-for-Growth initiative to eliminate investments in non-core businesses, we completed the sale of ~~the Cincinnati Sub-Zero industrial chamber business (“CSZ-IC”) and former Cincinnati Sub-Zero headquarters facility~~CSZ-IC to Weiss Technik North America, Inc. for total cash proceeds of $47.5 million, including $2.5 million of cash proceeds placed into an escrow account for a period of up to one year as partial security for the Company’s obligations under the sale agreement. In connection with the sale, Gentherm entered into an operating lease agreement for a portion of the office and manufacturing building space purchased by Weiss Technik North America, Inc. The Company recognized a ~~$4,970 million~~ pre-tax gain of $5.0 million on the sale of CSZ-IC during the ~~nine-months~~three months ended ~~September 30,~~March 31, 2019.

~~Manufacturing Footprint Rationalization~~Impairment Loss

Below is a summary of our impairment loss, in thousands, for the three months ended March 31, 2020 and March 31, 2019:

Three Months Ended March 31,

2020

2019

Favorable /

(Unfavorable)

Impairment loss

—

(10,484

)

10,484

During the three months ended March 31, 2019, the Company recorded an impairment loss of $10.5 million associated with the divestiture of GPT. See Note 3, “Acquisitions and Divestitures” of the consolidated condensed financial statements included in this Report for additional information.

Other income

Below is a summary of our other income, in thousands, for the three months ended March 31, 2020 and March 31, 2019:

Three Months Ended March 31,

2020

2019

Favorable /

(Unfavorable)

Other income

264

143

121

The increase in other income is primarily due to an increase in miscellaneous income.

~~On September 23,~~Income Tax Expense

Below is a summary of our income tax expense, in thousands, for the three months ended March 31, 2020 and March 31, 2019:

Three Months Ended March 31,

2020

2019

Favorable /

(Unfavorable)

Income tax expense

5,406

6,895

1,489

Income tax expense was $5.4 million for the three months ended March 31, 2020, on earnings before income tax of $17.3 million, representing an effective tax rate of 31.3%. The effective tax rate differed from the U.S. Federal statutory rate of 21% primarily due to the international provisions of the U.S. tax reform, such as global intangible low-tax income (“GILTI”), enacted in December 2017, partly offset by certain intercompany transactions which disproportionately benefited lower tax rate jurisdictions.

Income tax expense was $6.9 million for the three months ended March 31, 2019, on earnings before income tax of $15.3 million, representing an effective tax rate of 45.0%. The pre-tax earnings amount included the non-deductible impairment loss of $10.5 million. Adjusted for the impairment loss, the effective tax rate was 26.7% for the three months ended March 31, 2019. The effective tax rate differed from the U.S. Federal statutory rate of 21% primarily due to the international provisions of the U.S. tax reform, such as GILTI, partly offset by certain intercompany transactions which disproportionately benefited lower tax rate jurisdictions.

Changes in U.S. federal or foreign tax laws and regulations, or their interpretation and application, including those with retroactive effect, could significantly impact our provision for income taxes, the amount of taxes payable, our deferred tax asset and liability balances, and shareholders’ equity. The recently enacted CARES Act, together with earlier issued IRS guidance, provides for deferral of certain taxes. As permitted by the CARES Act, the Company ~~committed~~expects to defer the payment of payroll taxes each quarter for the remainder of 2020 to be paid in the fourth quarters of 2021 and 2022. The Company is evaluating other potential tax benefits under the CARES Act and may be impacted by further government tax guidance or relief.

Liquidity and Capital Resources

Cash and Cash Flows

The Company historically has funded its liquidity needs primarily through cash flows from operating activities and equity and debt financings. Prior to the COVID-19 pandemic, we were focused on a ~~restructuring~~capital allocation strategy within our strategic plan that included a targeted debt-to-earnings leverage ratio and using a portion of our cash flow for Common Stock repurchases. As of March 31, 2020, $74.2 million of availability remained under the stock repurchase program.

In light of the significant economic uncertainty and financial impact of the COVID-19 pandemic, the Company has taken significant actions to ~~improve~~address its liquidity. First, the Company has been prudently addressing its day-to-day operations, including reducing expenses, inventory levels and capital spending. In addition, effective May 1, 2010, the Company implemented base salary deferrals until December 31, 2020, including a 30-40% deferral at the Executive level and a 20% deferral for other salaried employees, to control expenses and conserve cash. For U.S. employees, the accumulated deferred base salary will generally be paid on or before March 15, 2021 notwithstanding any termination of employment for any reason prior to payment. The Company also revised its non-employee director compensation program for directors elected at the 2020 annual meeting of shareholders, with all compensation being paid in restricted stock for one year. Further, the Company has suspended its stock repurchase program to preserve liquidity.

Also, in March 2020, the Company increased its borrowings under the Amended Credit Agreement by $169.5 million as a safeguard to increase its cash position and provide additional financial flexibility. The proceeds will be used for working capital and for other general corporate purposes permitted by the Amended Credit Agreement. As of March 31, 2020, inclusive of the new borrowings, $225.4 million was outstanding under the Amended Credit Agreement. Based upon consolidated EBITDA for the twelve months ended March 31, 2020, $226.7 remains available for additional borrowings under the Amended Credit Agreement subject to specified conditions that Gentherm currently satisfies. The Company may incur additional significant borrowing in the near term. The determination of additional borrowing amounts will be evaluated based upon the Company’s ~~manufacturing productivity~~ongoing performance, the current economic and ~~rationalize~~industry outlook and the desire to provide additional financial flexibility. Future borrowing availability under the Amended Credit Agreement is subject to the Company’s compliance with financial covenants thereunder (including the Consolidated Leverage Ratio). The Company expects its ~~footprint. Under this plan,~~consolidated EBITDA for the trailing 12 months to continue to be significantly reduced as of the end of the second quarter 2020 due to the COVID-19 impact and it may continue to deteriorate thereafter. Therefore, subject to any amendment or waiver of the Consolidated Leverage Ratio from the lenders, the Company expects future borrowing availability will ~~relocate~~be materially less than the full amount of capacity available under the U.S. Revolving Note. The Company expects that its lenders will agree to an amendment or waiver to increase the borrowing availability if necessary. Based on the Company’s current operating plan and ~~consolidate certain existing automotive manufacturing~~the foregoing actions, management believes cash and cash equivalents at March 31, 2020, together with cash flows from operating activities, and borrowing available under our Amended Credit Agreement, are sufficient to meet operating and capital expenditure needs, and to service debt, for at least the next 12 months. However, as the impact of the COVID-19 pandemic on the economy and our operations evolves, and cash flows from operations decline, we may need to obtain alternative sources of capital, and we may finance additional liquidity needs in the future through one or more equity or debt offerings.

A continued worldwide disruption could materially affect our future access to sources of liquidity, and there can be no assurance that such capital will be available at all or on reasonable terms. The extent to which the COVID-19 pandemic adversely affects our future financial performance will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the pandemic, its severity, the effectiveness of actions to contain the virus or treat its impact and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 pandemic has subsided, we may continue to experience significant adverse impacts on our business and financial performance for a lengthy period of time as a result ~~certain~~of its global economic impact.

The following table represents our cash, cash equivalents and restricted cash, in thousands:

	Three Months Ended March 31,
	2020			2019
Cash, cash equivalents and restricted cash at beginning of period	$	52,948		$	39,620
Cash provided by operating activities		29,419			6,881
Cash (used in) provided by investing activities		(6,338	)		42,378
Cash provided by (used in) financing activities		149,841			(47,401	)
Foreign currency effect on cash and cash equivalents		(426	)		(209	)
Cash, cash equivalents and restricted cash at end of period	$	225,444		$	41,269

Cash Flows From Operating Activities

We manage our cash, cash equivalents and restricted cash in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. The following table compares the cash flows from operating activities during the three months ended March 31, 2020 as compared to the three months ended March 31, 2019, in thousands:

	Three Months Ended
	March 31,
	2020			2019			Change
Operating Activities:
Net income	$	11,873		$	8,414		$	3,459
Non-cash adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization		10,406			11,052			(646	)
Deferred income taxes		721			1,749			(1,028	)
Stock based compensation		1,942			1,968			(26	)
Defined benefit pension plan income (expense)		85			(617	)		702
Allowance for credit losses		451			229			222
Loss on sale of property and equipment		119			178			(59	)
Operating lease expense		1,651			1,333			318
Impairment loss		—			10,484			(10,484	)
Gain on sale of business		—			(4,970	)		4,970
Net income before non-cash adjustments		27,248			29,820			(2,572	)
Changes in operating assets and liabilities:
Accounts receivable		(2,491	)		(8,293	)		5,802
Inventory		(404	)		(229	)		(175	)
Other assets		(4,805	)		(5,553	)		748
Accounts payable		13,540			(2,079	)		15,619
Other liabilities		(3,669	)		(6,785	)		3,116
Net cash provided by operating activities	$	29,419		$	6,881		$	22,538

The following table highlights significant differences between the operating cash flows for the three months ended March 31, 2020 and March 31, 2019, respectively, in thousands:

Net cash provided by operating activities for the three months ended March 31, 2019	$	6,881
Lower net income before changes in operating assets and liabilities		(2,572	)
Changes in working capital, net		26,044
Changes in other assets and liabilities		(934	)
Net cash provided by operating activities for the three months ended March 31, 2020	$	29,419

Net cash provided by operating activities before changes in operating assets and liabilities increased during the three months ended March 31, 2020 primarily due to higher net income and lower operating expenses. Additionally, working capital, net provided unfavorable cash flows related to accounts receivable, inventory and other assets and favorable amounts related to accounts payable and other liabilities.

The following table illustrates changes in working capital during the three months ended March 31, 2020, in thousands:

Working capital at December 31, 2019	$	217,159
Increase in cash, cash equivalents and restricted cash		174,024
Increase in accounts receivable		560
Increase in inventory		555
Decrease in tax receivables, net		(1,896	)
Increase in other assets		3,475
Increase in accounts payable		(14,794	)
Increase in accrued expenses and other liabilities		(139	)
Foreign currency effect on working capital		(3,207	)
Working capital at March 31, 2020	$	375,737

The following table highlights significant transactions that contributed to the increase in cash, cash equivalents and restricted cash during the three months ended March 31, 2020, in thousands:

Net cash provided by operating activities	$	29,419
Purchases of property and equipment		(3,231	)
Repayments of debt		(16,111	)
Borrowings from U.S. Revolving Note		169,546
Stock repurchases		(9,092	)
Proceeds from the exercise of Common Stock options		5,902
Acquisition of intangible assets		(3,141	)
Proceeds from the sale of property and equipment		34
Other items		(830	)
Increase in cash, cash equivalents and restricted cash	$	172,496

Cash Flows From Investing Activities

Cash used in investing activities ~~overall reducing~~was $6.3 million during the ~~number~~three months ended March 31, 2020, primarily reflecting purchases of ~~plants by two. The Company expects to incur total costs~~property and equipment of ~~between $20.0~~$3.2 million and ~~$24.0~~the acquisition of intangible assets of $3.1 million.

Cash Flows From Financing Activities

Cash provided by financing activities was $149.8 million during the three months ended March 31, 2020, reflecting additional borrowings on the U.S. Revolving Note totaling $169.5 million partially offset by payments of ~~which between $17.0~~principal on the U.S. Revolving Note totaling $16.1 million in aggregate. Borrowings under the Amended Credit Agreement mature on June 27, 2024. See Note 11, “Debt” of the consolidated condensed financial statements included in this Report for additional information. Cash was also paid during the three months ended March 31, 2020 for the repurchase of Common Stock totaling $9.1 million and ~~$21.0~~for cancellations of restricted stock awards totaling $0.4 million, are expected to be cash expenditures. The total expected costs include employee separation costs of between $9.0 million and $11.0 million, capital expenditures of between $4.5 million and $5.5 million and non-cash expenses for accelerated depreciation and impairment of fixed assets of approximately $3.0 million. The Company also expects to incur other transition costs including recruiting, relocation, and machinery and equipment move and set up costs of between $3.5 million and $4.5 million. The actions under this plan are expected to be substantially completedpartially offset by ~~the end of 2021. The actual timing, costs and savings of the Plan may differ materially~~proceeds from the ~~Company’s current expectations and estimates~~

~~During the third quarter~~exercise of 2019, the Company recognized expense of $5.2 million for employee separation costs that will be paid pursuant to the terms of statutory requirements of the affected locations. Additionally, the Company recognized $1.6 million of accelerated depreciation and fixed asset impairment.Common Stock options totaling $5.9 million.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our consolidated condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. For discussion of our significant accounting policies, see Note 2, “Summary of Significant Accounting Policies, ~~and Basis of Presentation,~~” to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, ~~2018. With the exception of leases, there~~2019. There have been no significant changes in our critical accounting ~~policy changes~~policies or critical accounting estimates during ~~the nine-months ended September 30, 2019. See Note 2 for information about the adoption of ASU 2016-02, “Leases”.~~

~~Results of Operations Third Quarter 2019 Compared with Third Quarter 2018~~

~~Product revenues. Product revenues by product category, in thousands, for the three-months ended September 30, 2019 (“Third Quarter 2019”) and 2018 (“Third Quarter 2018”) are as follows:~~

Three Months Ended
September 30,

2019

2018

% Change

Climate Control Seats (CCS)

$
88,133

$
97,578

(9.7
)%
Seat Heaters

71,030

70,768

0.4
%
Steering Wheel Heaters

16,621

18,095

(8.1
)%
Automotive Cables

20,361

24,961

(18.4
)%
Battery Thermal Management (BTM)^(a)

11,890

7,461

59.4
%
Electronics

11,729

12,590

(6.8
)%
Other Automotive

8,479

7,396

14.6
%
Subtotal Automotive

$
228,243

$
238,849

(4.4
)%
Remote Power Generation (GPT)

3,477

4,378

(20.6
)%
Industrial Chambers

—

9,829

(100.0
)%
Gentherm Medical

8,336

8,448

(1.3
)%
Subtotal Industrial

$
11,813

$
22,655

(47.9
)%
Total Company

$
240,056

$
261,504

(8.2
)%

a)	Battery Thermal Management or BTM product revenues include Gentherm’s automotive grade, low cost, heat resistant fans and blowers used by customer for battery cooling through ventilation and production level shipments of the advanced TED based active cool system.

Product revenues for the Third Quarter 2019 were $240.1 million compared with product revenues of $261.5 million during Third Quarter 2018, a decrease of $21.4 million, or 8.2%. The decrease included lower revenues in the automotive segment, which decreased by $10.6 million, or 4.4%, to $228.2 million, and lower industrial segment product revenues which decreased $10.8 million, or 47.9%, to $11.8 million.

Our automotive segment revenues decreased primarily due to unfavorable foreign currency, automotive volumes, and pricing. Unfavorable currency decreased revenues by $3.8 million, primarily attributable to the Euro, Chinese Renminbi and Korean Won. Unfavorable automotive volumes decreased revenues by $3.6 million, including the impact of the strike at General Motors which decreased revenues by approximately $3 million. Other reductions, primarily associated with reduced customer pricing, decreased revenues by $3.2 million.

Our industrial segment revenues decreased primarily due to the absence of revenue from CSZ-IC, which was sold on February 1, 2019, as well as lower revenue from GPT. Additionally, excluding the impact of the Stihler acquisition, Gentherm Medical revenue decreased approximately $1.5 million.

~~Cost of Sales.~~ Cost of sales was $165.4 million during Third Quarter 2019 compared to $185.8 million during Third Quarter 2018, a decrease of $20.4 million, or 11.0%. This decrease was primarily associated with the sale of CSZ-IC in the first quarter of ~~2019, favorable currency impact, decreases in automotive volumes and operational performance improvements, including Fit-for-Growth. Additionally, the Third Quarter 2019 included a one-time benefit~~2020. We are not presently aware of approximately $1 million related to the release of an automotive warranty accrual upon resolution of a prior year quality issue. These items were offset by higher labor costs in Mexico, Macedonia and China.

The sale of CSZ-IC decreased cost of sales by $7.6 million. Operational performance improvements decreased cost of sales by $8.2 million, primarily attributable to decreases in overtime, expedited freight, material costs and quality costs. Favorable currency decreased cost of sales by $2.2 million primarily attributable to the Euro, Chinese Renminbi and Mexican Peso.

~~Net Research and Development Expenses.~~ ~~Net research and development expenses were $18.8 million during Third Quarter 2019 compared to $19.1 million during Third Quarter 2018, a decrease of $0.3 million,~~any events or 1.1%. The decrease in net research and development expenses is primarily related to lower incentive compensation costs and the Company’s focused portfolio and Fit-for-Growth cost reduction initiatives. These decreases in expense are offset by decreases in reimbursed research and development.

~~Reimbursed research and development totaled $3.2 million during Third Quarter 2019 compared to $5.5 million during Third Quarter 2018.~~

~~Selling, General and Administrative Expenses.~~ Selling, general and administrative expenses were $26.9 million during Third Quarter 2019 compared to $35.1 million during Third Quarter 2018, a decrease of $8.2 million, or 23.4%. The decrease was primarily related to the sale of CSZ-IC on February 1, 2019, lower incentive compensation costs and the Company’s focused portfolio and Fit-for-Growth cost reduction initiatives. Additionally, Third Quarter 2018 included a $3.3 million mark-to-market charge on cash paid stock options that did not repeat in Third Quarter 2019.

~~Restructuring expenses.~~ The Company recognized $8.7 million in restructuring expenses during Third Quarter 2019 primarily associated with the Manufacturing Footprint Rationalization restructuring program. Total restructuring expenses included $6.7 million of employee separation costs, $1.6 million of accelerated depreciation and fixed asset impairment and $0.4 of other related costs.

~~Foreign currency gain.~~ ~~During Third Quarter 2019 we incurred a net foreign currency gain of $4.1 million which included a net realized gain of $0.5 million and a net unrealized gain of $3.6 million.~~

~~Impairment loss.~~ During Third Quarter 2019, the Company recorded an impairment loss totaling $0.8 million associated with the Company’s plans to divest GPT. The loss is not expected to be deductible for income tax purposes.

~~Income Tax Expense.~~ We recorded an income tax expense of $6.8 million during Third Quarter 2019 on earnings before income tax of $22.7 million. The pre-tax earnings amount included the non-deductible impairment loss of $0.8 million. Adjusted for the impairment loss, the effective tax rate was 28.8% for the Third Quarter 2019. During Third Quarter 2018, we recorded an income tax expense of $3.7 million on earnings before tax of $3.3 million. The pre-tax earnings amount included the non-deductible impairment loss of $11.5 million. Adjusted for the impairment loss, the effective tax rate was 24.9% for the Third Quarter 2018. The effective tax rate for Third Quarter 2018 differedcircumstances arising from the ~~Federal statutory rate~~COVID-19 pandemic that would require us to update our estimates, judgments or revise the carrying value of ~~21% primarily due~~our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained. As a result, actual results may differ significantly from our estimates, and any such differences may be material to ~~increased international provisions from the U.S. tax reform, such as global intangible low-tax income (“GILTI”), enacted in December 2017, partly offset by favorable excess tax benefits~~our financial statements. For information on stock option exercises and certain intercompany transactions which disproportionately benefited lower tax rate jurisdictions. The effective tax rate for Third Quarter 2019 was higher than the Federal statutory rate of 21% primarily due to the impact of ~~higher statutory rates for our subsidiaries operating~~recently issued accounting pronouncements, see Note 2, “New Accounting Pronouncements” in ~~foreign jurisdictions and effects from~~ the ~~U.S. tax reform, such as GILTI.~~consolidated condensed financial statements included in this Report.

~~Results of Operations Year to Date 2019 Compared with Year to Date 2018~~Off-Balance Sheet Arrangements

~~Product revenues. Product revenues by product category, in thousands, for the nine-months ended September 30, 2019 (“YTD 2019”) and 2018 (“YTD 2018”)~~At March 31, 2020, we do not have any off-balance sheet arrangements that have, or are, ~~as follows:~~

Nine Months Ended
September 30,

2019

2018

% Change

Climate Control Seats (CCS)

$
270,924

$
276,191

(1.9
)%
Seat Heaters

218,578

235,164

(7.1
)%
Steering Wheel Heaters

49,620

53,192

(6.7
)%
Automotive Cables

66,316

77,471

(14.4
)%
Battery Thermal Management (BTM)^(a)

31,531

18,863

67.2
%
Electronics

36,035

44,409

(18.9
)%
Other Automotive

27,296

19,130

42.7
%
Subtotal Automotive

$
700,300

$
724,420

(3.3
)%
Remote Power Generation (GPT)

11,181

14,310

(21.9
)%
Industrial Chambers

3,418

30,460

(88.8
)%
Gentherm Medical

26,404

23,300

13.3
%
Subtotal Industrial

$
41,003

$
68,070

(39.8
)%
Total Company

$
741,303

$
792,490

(6.5
)%

a)	Battery Thermal Management or BTM product revenues include Gentherm’s automotive grade, low cost, heat resistant fans and blowers used by customer for battery cooling through ventilation and production level shipments of the advanced TED based active cool system.

~~Product revenues during YTD 2019 were $741.3 million compared with product revenues of $792.5 million during YTD 2018, a decrease of $51.2 million, or 6.5%. The decrease included lower revenues~~ in the ~~automotive segment, which decreased by $24.1 million,~~opinion of management, reasonably likely to have, a current or ~~3.3%, to $700.3 million and lower industrial segment product revenues which decreased $27.1 million,~~future material effect on our financial condition or ~~39.8%, to $41.0 million.~~results of operations.

Our automotive segment revenues decreased primarily due to unfavorable foreign currency and pricing offset by increased volumes. Unfavorable currency decreased revenues by $16.7 million, primarily attributable to the Euro, Chinese Renminbi and Korean Won. Favorable volumes increased revenues by $1.6 million. Other reductions primarily associated with customer pricing, decreased revenues by $9.0 million.

~~Our industrial segment revenues decreased primarily due to the sale~~Effects of ~~CSZ-IC on February 1, 2019, as well as lower revenue from GPT. These decreases were partially offset by increased revenue from Gentherm Medical.~~

~~Cost of Sales.~~ Cost of sales was $518.6 million during YTD 2019 compared to $558.5 million during YTD 2018, a decrease of $39.9 million, or 7.1%. This decrease was primarily associated with the sale of CSZ-IC in the first quarter of 2019, favorable currency impact and operational improvements, including Fit-for-Growth. These items were offset by increased U.S. tariffs, automotive volumes and higher labor costs in Mexico, Macedonia and China.Inflation

The ~~sale of CSZ-IC decreased cost of sales by $20.8 million. Operational performance improvements decreased cost of sales by $19.1 million, primarily attributable~~automotive component supply industry is subject to ~~decreases in headcount, overtime, expedited freight~~inflationary pressures with respect to raw materials and ~~material costs. Favorable currency decreased cost of sales by $10.3 million primarily attributable to the Euro, Chinese Renminbi~~labor, which have historically placed operational and ~~Mexican Peso.~~

~~Net Research and Development Expenses.~~ Net research and development expenses were $57.0 million during YTD 2019 compared to $63.4 million during YTD 2018, a decrease of $6.4 million, or 10.1%. The decrease in net research and development expenses is primarily related to the Company’s focused portfolio and Fit-for-Growth cost reduction initiatives.

~~Reimbursed research and development totaled $12.0 million during YTD 2019 compared to $12.5 million during YTD 2018.~~

~~Selling, General and Administrative Expenses.~~ Selling, general and administrative expenses were $91.7 million during YTD 2019, a decrease of $14.1 million, or 13.3%, from $105.8 million during YTD 2018. The decrease was primarily related to the sale of CSZ-IC on February 1, 2019 and the Company’s focused portfolio and Fit-for-Growth cost reduction initiatives.

~~Restructuring expenses.~~ The Company recognized $11.8 million in restructuring expenses during YTD 2019 primarily associated with the Manufacturing Footprint Rationalization restructuring program and other discrete restructuring actions which represented $6.8 million and $3.4 million, respectively. Total costs for the YTD 2019 included $8.2 million of employee separation costs, $2.0 million of accelerated depreciation and impairment charges and $1.6 million of other related costs.

~~Foreign currency gain (loss).~~ ~~During YTD 2019 we incurred a net foreign currency gain of $3.5 million which included a net realized loss of $1.0 million and a net unrealized gain of $4.5 million.~~

~~Gain on sale of business.~~ On February 1, 2019, as part of Company’s Fit-for-Growth initiative to eliminate investments in non-core businesses, we completed the sale of the CSZ-IC and former Cincinnati Sub-Zero headquarters facility to Weiss Technik North America, Inc. for total cash proceeds of $47.5 million, including $2.5 million of cash proceeds that were placed into an escrow account for a period of up to one year. The Company recognized a pre-tax gain of $5.0 millionfinancial burdens on the ~~sale of CSZ-IC during the nine months ended September 30, 2019.~~

~~Impairment loss.~~ ~~During the YTD 2019,~~entire supply chain. Accordingly, the Company ~~recorded an impairment loss totaling $21.2 million associated~~continues to take actions with ~~the Company’s plans~~its customers and suppliers to ~~divest GPT. The loss is not expected to be deductible for income tax purposes.~~

~~Income Tax Expense.~~ We recorded an income tax expense of $19.2 million during YTD 2019 on earnings before income tax of $46.3 million. The pre-tax earnings amount included the non-deductible impairment loss of $21.2 million. Adjusted for the impairment loss, the effective tax rate was 28.5% for the YTD 2019. During YTD 2018, we recorded an income tax expense of $9.8 million on earnings before tax of $39.1 million. The pre-tax earnings amount included the non-deducible impairment loss of $11.5 million. Adjusted for the impairment loss, the effective tax rate was 19.4% for YTD 2018. The effective tax rate for YTD 2018 differed from the Federal statutory rate of 21% primarily due tomitigate the impact of ~~discrete adjustments, including favorable excess tax~~these inflationary pressures in the future. Actions to mitigate inflationary pressures with customers include collaboration on alternative product designs and material specifications, contractual price escalation clauses and negotiated customer recoveries. Actions to mitigate inflationary pressures with suppliers include aggregation of purchase requirements to achieve optimal volume benefits, ~~on stock option exercises~~negotiation of cost-reductions and ~~certain intercompany transaction which disproportionately benefited lower tax rate jurisdictions which were partially~~identification of more cost competitive suppliers. While these actions are designed to offset ~~by the international provisions from the US tax reform, such as GILTI, enacted in December 2017. The effective tax rate for YTD 2019 was higher than the Federal statutory rate of 21% primarily due to~~ the impact of ~~higher statutory rates for our subsidiaries operating in foreign jurisdictions and effects from~~inflationary pressures, the ~~U.S. tax reform, such as GILTI.~~

~~Liquidity and Capital Resources~~

~~Cash and Cash Flows~~

~~The~~ Company has funded its financial needs primarily through cash flows from operating activities and equity and debt financings. Our new strategic plan sets forth a capital allocation strategy that includes a targeted debt-to-earnings leverage ratio and allows for some of our cash flows to be paid back to investors through Common Stock repurchases. On June 25, 2018, our Board of Directors increased the Company’s stock repurchase authorization to $300 million, of which $88.6 million of availability remained as of September 30, 2019. This authorization expires on December 16, 2020. Based on its current operating plan, management believes cash and cash equivalents at September 30, 2019, together with cash flows from operating activities, and borrowings available under our credit agreement, are sufficient to meet operating and capital expenditure needs, and to service debt, for at least the next 12 months. However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and adversely affect our results of operations and financial condition. In addition, it is likely that we will need to complete one or more equity or debt financings if we consummate any significant acquisition or several smaller acquisitions. There can be nocannot provide assurance that ~~such capital~~it will be ~~available at all or on reasonable terms, which could adversely affect our future operations and business strategy.~~

~~The following table represents our cash and cash equivalents and restricted cash:~~

Nine Months Ended
September 30,

2019

2018

(In thousands)

Cash, cash equivalents and restricted cash at beginning of
period

$
39,620

$
103,172

Cash provided by operating activities

83,992

70,541

Cash provided by (used in) investing activities

14,474

(31,127
)
Cash used in financing activities

(86,231
)

(94,181
)
Foreign currency effect on cash and cash equivalents

(4,151
)

(1,253
)
Cash, cash equivalents and restricted cash at end of period

$
47,704

$
47,152

~~Cash Flows From Operating Activities~~

~~We manage our cash, cash equivalents and restricted cash~~successful in ~~order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. The following table compares the cash flows~~fully offsetting increased costs resulting from ~~operating activities during YTD 2019 and YTD 2018:~~

Nine Months Ended
September 30,

2019

2018

Change

(In thousands)

Operating Activities:

Net income

$
27,052

$
29,270

$
(2,218
)
Non-cash adjustments to reconcile net income to cash
provided by operating activities:

Depreciation and amortization

33,281

38,721

(5,440
)
Deferred income taxes

5,072

(19
)

5,091

Stock compensation

5,268

6,360

(1,092
)
Defined benefit plan income

(754
)

(219
)

(535
)
Provision for doubtful accounts

209

247

(38
)
Loss on sale of property and equipment

319

2,273

(1,954
)
Operating lease expense

4,477

—

4,477

Impairment loss

21,206

11,476

9,730

Gain on sale of business

(4,970
)

—

(4,970
)
Other

189

—

189

Net income before changes in operating assets
and liabilities

91,349

88,109

3,240

Changes in operating assets and liabilities:

Accounts receivable

(6,170
)

(13,855
)

7,685

Inventory

(5,512
)

(3,510
)

(2,002
)
Prepaid expenses and other assets

9,594

(7,867
)

17,461

Accounts payable

(3,097
)

8,376

(11,473
)
Accrued liabilities

(2,172
)

(712
)

(1,460
)
Net cash provided by operating activities

$
83,992

$
70,541

$
13,451

Cash provided by operating activities during YTD 2019 was $84.0 million, representing an increase of $13.5 million from cash provided by operating activities during YTD 2018, which was $70.5 million. The following table highlights significant differences between the operating cash flows for the nine months ended September 30, 2019 and 2018, respectively:

(In thousands)

Net cash provided by operating activities during YTD 2018

$
70,541

Decrease from lower net income before changes in operating assets
and liabilities

3,240

Changes in working capital, net

20,493

Changes in other assets and liabilities, net

(10,282
)
Net cash provided by operating activities during YTD 2019

$
83,992

Net cash provided by operating activities before changes in operating assets and liabilities increased during YTD 2019 due to non-cash impairment losses of $21.2 million, partially offset by a $5.0 gain recognized on the sale of CSZ-IC. Additionally, working capital, net provided unfavorable cash flows related to accounts payable and accrued liabilities and favorable amounts related to accounts receivable, inventory and prepaid expenses and other assets.

~~The following table illustrates changes in working capital during YTD 2019:~~

(In thousands)

Working capital at December 31, 2018

$
267,679

Increase in cash, cash equivalents and restricted cash

6,340

Impairment loss on assets classified as held for sale

(21,206
)
Foreign currency effect on working capital

(5,044
)
Increase in accounts receivable

6,454

Decrease in tax receivables

(9,137
)
Increase in inventory

6,376

Decrease in prepaid expenses and other assets

(3,110
)
Decrease in accounts payable

2,591

Increase in accrued liabilities

(5,780
)
Decrease in working capital due to the sale of a business

(42,530
)
Increase in net current assets classified as held for sale

6,505

Increase in working capital from acquisition of new company

5,203

Working capital at September 30, 2019

$
214,341

~~The following table highlights significant transactions that contributed to the increase in cash, cash equivalents and restricted cash during the nine-months ended September 30, 2019:~~

(in Thousands)

Net cash provided by operating activities

$
83,992

Purchases of property and equipment

(18,340
)
Repayments of Debt

(69,049
)
Borrowings from U.S. Revolving Note

29,470

Stock repurchases

(58,040
)
Proceeds from the exercise of common stock options

13,879

Proceeds from the sale of CSZ-IC

47,500

Cash paid for acquisition of subsidiary

(14,823
)
Other items

(8,249
)
Increase in cash

$
6,340

In addition to these transactions, working capital was impacted by increases in accounts receivable, inventory, accrued liabilities, and decreases in prepaid expenses and other assets, accounts payable, and tax receivables. The changes in current assets and liabilities reflect the classification of additional assets related to GPT (disposal group) as held for sale during YTD 2019. All assets and liabilities of the disposal group are classified as held for sale within current assets and current liabilities, respectively, on the Company’s consolidated balance sheet as of September 30, 2019. See Note 4 to our consolidated condensed financial statement for additional information about the assets and liabilities classified as held for sale.

~~Cash Flows From Investing Activities~~

Cash provided by investing activities was $14.5 million during YTD 2019, reflecting cash proceeds of $47.5 million related to the sale of CSZ-IC, offset by the acquisition of Stihler for $14.8 million and the purchases of property and equipment related to the expansion of production capacity, totaling $18.3 million.

~~Cash Flows From Financing Activities~~

Cash used in financing activities was $86.2 million during YTD 2019, reflecting payments of principal on the U.S. Revolving Note, the DEG China Loan and the DEG Vietnam Loan totaling $69.0 million in aggregate partially offset by additional borrowings on the U.S. Revolving Note totaling $29.5 million. As of September 30, 2019, the total availability under the U.S. Revolving Note was $385.1 million. Cash was also paid in YTD 2019 for the repurchase of Common Stock totaling $58.0 million, financing costs incurred with for the Amended and Restated Credit Agreement totaling $1.3 million and cancellations of restricted stock awards totaling $1.2 million, partially offset by proceeds from the exercise of common stock options totaling $13.9 million.

~~Off-Balance Sheet Arrangements~~

We use letters of credit to guarantee our performance under specific construction contracts executed by our subsidiaries, GPT and Gentherm Medical. The expiration dates of the letter of credit contracts coincide with the expected completion date of the contract. Extensions are normally made if performance obligations continue beyond the expected completion date. At September 30, 2019, we had outstanding letters of credit of $72 thousand, a decrease from $455 thousand at December 31, 2018. inflationary pressure.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our exposure to market risk for changes in interest rates relates primarily to our debt obligations and foreign currency contracts. We have in the past, and may in the future, place our investments in bank certificates of deposits, debt instruments of the U.S. government, and in high-quality corporate issuers.

We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material ~~commodities such as copper.~~commodities. Market risks for changes in interest rates relate primarily to our debt obligations under our Amended Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of ~~$25.2~~$22.2 million and ~~$33.3~~$14.4 million outstanding at ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018,~~2019, respectively.

The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years. No commodity swap contracts were outstanding at September 30, 2019 or at December 31, 2018.

We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive loss in the consolidated condensed balance sheets. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive loss is recorded in earnings in the consolidated condensed statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency (loss) gain in the consolidated condensed statements of income. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

Information related to the fair values of all derivative instruments in our consolidated condensed balance sheet as of ~~September 30, 2019~~March 31, 2020 is set forth in Note ~~12 to~~13, “Financial Instruments” in the consolidated condensed financial statements included ~~herein.~~in this Report.

Interest Rate Sensitivity

The table presents principal cash flows and related weighted average interest rates by expected maturity dates for each of the Company’s debt obligations. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in U.S. dollars ($USD) or Euros (€EUR), as indicated in parentheses.

~~September 30, 2019~~

Expected Maturity Date

2019

2020

2021

2022

2023

2024

Total

Fair
Value

(In thousands except rate information)

Liabilities

Long Term Debt:

Variable Rate (€EUR)

$
—

—

—

—

—

19,623

$
19,623

$
19,623

Variable Interest Rate as of September 30, 2019

1.25
%

1.25
%

Variable Rate ($USD)

—

—

—

—

70,000

$
70,000

$
70,000

Variable Interest Rate as of September 30, 2019

3.29
%

3.29
%

Fixed Rate ($USD)

$
1,250

$
2,500

$
2,500

$
2,500

$
1,250

—

$
10,000

$
10,213

Fixed Interest Rate

5.21%

5.21%

5.21%

5.21%

5.21%

5.21%

	Expected Maturity Date
	2020			2021			2022			2023			2024			2025		Total			Fair Value
Liabilities
Long-Term Debt:
Variable rate (€EUR)	$	—		$	—		$	—		$	—		$	42,417		$	—	$	42,417		$	42,417
Variable interest rate as of March 31, 2020														1.25	%				1.25	%
Variable rate ($USD)	$	—		$	—		$	—		$	—		$	183,000		$	—	$	183,000		$	183,000
Variable interest rate as of March 31, 2020														2.20	%				2.20	%
Fixed rate ($USD)	$	2,500		$	2,500		$	2,500		$	1,250		$	—		$	—	$	8,750		$	9,063
Fixed interest rate		5.21	%		5.21	%		5.21	%		5.21	%							5.21	%

Exchange Rate Sensitivity

The table below provides information about the Company’s foreign currency forward exchange rate agreements that are sensitive to changes in foreign currency exchange rates. The table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates for each type of foreign currency forward exchange agreement. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

~~September 30, 2019~~

Expected Maturity or Transaction Date

Anticipated Transactions And Related Derivatives

2019

2020

Total

Fair
Value

(In thousands except rate information)

$U.S. functional currency

Forward Exchange Agreements:

(Receive MXN/Pay USD$)

Total Contract Amount

$
10,726

$
14,484

$
25,210

$
897

Average Contract Rate

20.98

20.71

20.83

	Expected Maturity or Transaction Date
Anticipated Transactions and Related Derivatives	2020		Total		Fair Value
USD Functional Currency
Forward Exchange Agreements:
(Receive $MXN / Pay $USD)
Total contract amount	$	22,176	$	22,176	$	(3,553	)
Average contract rate		20.29		20.29

ITEM 4.

CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

~~As disclosed~~Due to the COVID-19 pandemic, a significant portion of our employees are now working from home, while also under shelter-in-place orders or other restrictions. Established business continuity plans were activated in order to mitigate the impact to our ~~Annual Report on Form 10-K for the year ended December 31, 2018, we identified a material weakness related to Information Technology General Controls (“ITGC”) at~~control environment, operating procedures, data and internal controls. The design of our wholly owned subsidiary, Gentherm Medical, LLC (formerly, Cincinnati Sub-Zero Products, LLC), which did not operate in a way to appropriately restrict elevated access and address segregation of duty conflicts at both the information technology and end user levels.

~~During the nine months ended September 30, 2019, in response to this material weakness, the Company implemented a remediation plan which included development of enhanced risk assessment procedures~~processes and controls ~~over the monitoring of elevated access and segregations of duty conflicts. We completed our testing of the operating effectiveness of the enhanced controls and found them~~allow for remote execution with accessibility to ~~be effective as of September 30, 2019. As a result, we have concluded that the material weakness has been remediated as of September 30, 2019.~~ secure data.

As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, ~~our Chief Executive Officer and Chief Financial Officer~~management has concluded that ~~as of September 30, 2019, our~~the Company’s disclosure controls and procedures were ~~effective.~~effective as of March 31, 2020.

(b) Changes in Internal Control over Financial Reporting

~~Except for the changes in connection with our implementation of the remediation plan discussed above, there~~There were no changes in the Company’s internal control over financial reporting during the three months ~~ended September 30, 2019,~~ending March 31, 2020, that have materially affected, or are ~~reasonable~~reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

We are subject to litigation from time to time in the ordinary course of business, however there is no ~~current~~ material pending litigation to which we are a party and no material legal proceeding was terminated, settled or otherwise resolved during the ~~nine~~three months ended ~~September 30, 2019.~~March 31, 2020.

ITEM 1A.

RISK FACTORS

~~There were no material changes in our~~You should carefully consider the risk factors below and previously disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2018. You should carefully consider~~2019.

The COVID-19 pandemic and measures taken to contain it have materially adversely affected, and are likely to continue to materially adversely affect, our business, results of operations and financial condition.

The COVID-19 pandemic has materially and adversely impacted the global economy and financial markets, with global legislative and regulatory responses including unprecedented monetary and fiscal policy actions across all sectors, and there is significant uncertainty as to timing of stabilization and recovery. Our business, results of operations and financial condition were materially adversely affected by the COVID-19 pandemic in the first quarter of 2020, especially beginning in March, and are likely to continue to be materially adversely affected, with such impact having materially worsened to date in the second quarter. The COVID-19 pandemic and measures taken to contain it have subjected our business, results of operations and financial condition to a number of material risks and uncertainties, including, but not limited to:

•

Risks Related to our Liquidity.We recently borrowed $169.5 million to provide financial flexibility and have taken other significant actions to conserve cash.As of March 31, 2020, our consolidated indebtedness was $225.4 million. Our increased indebtedness will result in, among other things, increased interest expense and may increase our vulnerability to future adverse economic and industry conditions. We may incur additional significant borrowing in the near term, which would increase risks related to indebtedness. In addition, future borrowing availability under our Amended Credit Agreement is subject to our compliance with financial covenants thereunder (including the Consolidated Leverage Ratio based on consolidated EBITDA for the applicable trailing 12-month period). Based upon consolidated EBITDA for the twelve months ended March 31, 2020, $226,743 remains available for additional borrowings under the Amended Credit Agreement subject to specified conditions that Gentherm currently satisfies. We expect our consolidated EBITDA for the trailing 12-months to be significantly reduced as of the end of the second quarter 2020 due to the COVID-19 impact and it may continue to deteriorate thereafter. Therefore, subject to any amendment or waiver from lenders, we expect our borrowing availability as of the end of the second quarter, and potentially thereafter, to be materially less than the full amount of capacity available. Failure to satisfy certain covenants in the Amended Credit Agreement would result in an event of default, following which our lenders could declare all amounts outstanding to be immediately due and payable and there is no guarantee that we would be able to repay, refinance, or restructure the payments on such debt on acceptable terms or at all. Further, under the Amended Credit Agreement, the lenders would have the right to foreclose on certain of our assets, which could have a material adverse effect on our business, liquidity, results of operations and financial condition. We may finance additional liquidity needs in the future through one or more equity or debt offerings. The current disruption of the global financial markets could reduce our ability to access additional capital on acceptable terms or at all, which would negatively affect our liquidity and may adversely impact our operations and results of operations.

•

Risks Related to the Automotive Industry. The automotive industry is our primary market. The COVID-19 pandemic has disrupted, and may continue to disrupt, the global automotive industry and customer sales, production volumes and purchases of light vehicles by end-consumers. Further, the spread of COVID-19 has created a disruption in the manufacturing, delivery and overall supply chain of automobile manufacturers and suppliers. In April 2020, IHS Markit forecasted light vehicle production volume for full-year 2020 of 69.3 million units, a decline of 22.0% from full-year 2019. Further, the COVID-19 pandemic has resulted in a temporary shutdown of substantially all of the major OEMs in our markets at various times in the first quarter 2020. This has significantly reduced our year-to-date sales volumes and revenue as compared to our budget, and future sales volumes and revenue remain highly uncertain. Even when automotive production resumes, customer sales and production volumes may continue to decrease or may be very volatile due to global economic impacts and uncertainties. Any prolonged reduction in actual revenues and anticipated reduction in projected revenues may require us to evaluate our intangible assets or goodwill for impairment.

•

Risks Related to our Supply Chain and our Manufacturing Operations. The COVID-19 pandemic has adversely impacted our ability to manufacture products and obtain materials from our supply chain. We and our suppliers have experienced facility closures, work stoppages, travel restrictions, implementation of precautionary health and safety measures and other

restrictions. We have experienced extended work stoppages in China, and subsequent suspension of vehicle production by our OEM customers in North America and Europe, which combined accounts for greater than 75% of our annual product revenue, as the pandemic spread to those regions and governmental authorities initiated “lock-down” orders for all non-essential activities. Due to the COVID-19 pandemic, a significant portion of our employees are now working from home, while under shelter-in-place orders or other restrictions, which may harm our ability to manage our business and increase operational risk, including increased cyber security attacks and reduced ability to implement security measures. Further, companies in our global supply chain are subject to distinct legislative and regulatory requirements and limitations. Certain companies in our supply chain have had significant employee layoffs or furloughs and have significant financial distress, and some may determine to cease operations or restructure their business. When business operations begin to resume, our suppliers may not be able to manufacture the materials and products we require according to our schedule and specifications, and we may need to seek alternate suppliers, which may be more expensive or may result in delays. Further, we and our suppliers and customers also will need to modify work or production methods, enhance health and hygiene requirements for the safety of employees and incur other unanticipated expenses to protect the welfare of employees. We expect that a portion of our employees may not want to or be able return to work when permitted due to health, safety, family or otherwise. As a result, we and our supply chain may operate significantly below capacity for an uncertain period of time even after operations resume, each of which could materially adversely affect our business, results of operations and financial condition.

•

Risks Related to our Customers. COVID-19 has and will continue to have a material adverse impact on the growth, viability and financial stability of our customers, including the OEMs and Tier 1 automotive suppliers to which our products are supplied. In addition to many of the risks noted above that apply to our customers regarding the automotive industry generally and our supply chain, we expect to continue to experience a delay in our collection of accounts receivable balances from our customers, which may be significant and would be at risk in the event of their bankruptcy or other restructuring.

•

Risks Related to our Growth Prospects. Our ability to execute our business strategy through the pursuit of business ventures, acquisitions, and strategic alliances or dispositions has been, and will likely continue to be, materially adversely impacted by COVID-19 and global economic conditions. While we continue to believe in our long-term growth strategy and prospects, we are limiting certain growth opportunities in the near term to conserve cash, including limiting the review of merger and acquisition opportunities and certain research and development activities. We also believe that the receipt of new business awards will be more limited in the near term, and such new business awards may be subject to increased risk of future change as we look to convert awards into revenue. Further, a sustained decline in automotive production may delay or reduce our returns on research and development investments, which could materially adversely affect our business, results of operations and financial condition.

•

Risks Related to Tax Matters. The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer-side social security payroll taxes, the allowance of a five-year net operating loss carryback period and the temporary suspension of the 80% net operating loss limitation, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. We currently expect to defer the payment of payroll taxes each quarter for the remainder of 2020, with such taxes to be paid in the fourth quarters of 2021 and 2022 as permitted by the CARES Act. We continue to examine the impacts the CARES Act may have on our business, but the extent to which we will benefit from the tax provisions in the CARES Act is currently unclear.

We are likely to continue to experience material adverse impacts for an uncertain period of time, even after business operations resume. The extent to which the COVID-19 pandemic materially adversely affects our business, results of operations and financial condition will depend on developments that are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the pandemic, its severity, the effectiveness of actions to contain the virus or treat its impact and how quickly and to what extent normal economic and operating conditions can resume. At this time, we are unable to predict whether the COVID-19 pandemic will result in permanent changes to the global automotive industry and our business practices or production capabilities.

In addition to the risks specifically described ~~therein.~~above, the COVID-19 pandemic has exacerbated and precipitated the other risks described in our Annual Report on Form 10-K for the year ended December 31, 2019, and may continue to do so, in ways that we are not currently able to predict, any of which could materially adversely affect our business, results of operations, financial condition, liquidity or stock price.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities During ~~Third~~First Quarter ~~2019~~2020

Period	(a) Total Number of Shares Purchased (1)		(b) Average Price Paid Per Share		(c) Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs		(d) Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (2)
January 1, 2020 to January 31, 2020		—	$	—		—		83,317,485
February 1, 2020 to February 29, 2020		—	$	—		—		83,317,485
March 1, 2020 to March 31, 2020		246,211	$	36.93		246,211		74,225,938

Period

(a)
Total Number
of Shares
Purchased (1)

(b)
Average
Price Paid
per Share

(c)
Total Number
of Shares
Repurchased
as Part of
Publicly
Announced
Plans or
Programs

(d)
Approximate
Dollar Value
of Shares
That May
Yet Be
Purchased
Under the
Plans or
Programs (2)

July 1, 2019 to July 31, 2019

213,565

$
40.20

213,565

104,974,519

August 1, 2019 to August 31, 2019

225,398

$
37.77

225,398

96,463,515

September 1, 2019 to September 30, 2019

195,662

$
40.50

195,662

88,559,879

(1)	All shares were purchased on the open-market in accordance with Gentherm’s ~~Stock Repurchase Program,~~stock repurchase program, including, in part, pursuant to a plan adopted by the Company in accordance with Rule 10b5-1 promulgated by the U.S. Securities and Exchange Commission.

(2)

The ~~Stock Repurchase Program~~stock repurchase program authorizes Gentherm to repurchase shares up to $300 million. The ~~Stock Repurchase Program~~stock repurchase program expires on December 16, 2020. The authorization of this ~~Stock Repurchase Program~~stock repurchase program does not require that the Company repurchase any specific dollar value or number of shares and may be modified, extended or terminated by the Company’s Board of Directors at any time. In March 2020, the Company suspended it share repurchase program in order to preserve liquidity. However, repurchases under the share repurchase program may resume at management’s discretion and may be made, from time to time, in amounts and at prices the Company deems appropriate, subject to market conditions, applicable legal requirements, debt covenants and other considerations.

ITEM 6.

EXHIBITS

Exhibits to this Report are as follows:

Incorporated by Reference

Exhibit
Number

Exhibit Description

Filed /Furnished Herewith

Form

Period Ending

Exhibit /
Appendix Number

Filing Date

3.1

Second Amended and Restated Articles of Incorporation of Gentherm Incorporated

8-K

3.2

3/5/18

3.2

Amended and Restated Bylaws of Gentherm Incorporated

8-K

3.1

5/26/16

10.1*

Form of Restricted Stock Unit Award Agreement (Performance-Based) under the 2013 Equity Incentive Plan (effective as of 2020 grants)

10.2*

Form of Restricted Stock Unit Award Agreement (Time-Based) under the 2013 Equity Incentive Plan (effective as of 2020 grants)

31.1

Section 302 Certification – CEO

31.2

Section 302 Certification – CFO

32.1**

Section 906 Certification – CEO

32.2**

Section 906 Certification – CFO

101.INS

Inline XBRL Instance Document – The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema Document.

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104

Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document

~~Incorporated by Reference~~

Exhibit
Number

~~Exhibit Description~~

~~Filed Herewith~~

~~Form~~

~~Period Ending~~

Exhibit /
Appendix Number

~~Filing Date~~

10.1*

~~Employment Contract between Gentherm GmbH and Thomas Stocker, effective [September 1, 2019]~~

~~31.1~~

~~Section 302 Certification – CEO~~

~~31.2~~

~~Section 302 Certification – CFO~~

32.1**

~~Section 906 Certification – CEO~~

32.2**

~~Section 906 Certification – CFO~~

~~101.INS~~

~~Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.~~

~~101.SCH~~

~~Inline XBRL Taxonomy Extension Schema Document.~~

~~101.CAL~~

~~Inline XBRL Taxonomy Extension Calculation Linkbase Document.~~

~~101.DEF~~

~~Inline XBRL Taxonomy Extension Definition Linkbase Document.~~

~~101.LAB~~

~~Inline XBRL Taxonomy Extension Label Linkbase Document.~~

~~101.PRE~~

~~Inline XBRL Taxonomy Extension Presentation Linkbase Document.~~

~~104~~

~~Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)~~

* Indicates management contract or compensatory plan or ~~arrangement~~arrangement.

** Documents are furnished not ~~filed~~filed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Gentherm Incorporated

	/s/ PHILLIP EYLER
	Phillip Eyler
	President ~~and~~& Chief Executive Officer
	(Principal Executive Officer)

	Date: ~~October 29, 2019~~May 7, 2020

	/s/ MATTEO ANVERSA
	Matteo Anversa
	Executive Vice President, Chief Financial Officer & Treasurer
	(Principal Financial Officer and Principal Accounting Officer)

	Date: ~~October 29, 2019~~May 7, 2020

3942

	Balance as of December 31, 2018		Adjustments due to adoption of ASU 2016-02			Balance as of January 1, 2019
Prepaid expenses and other assets		54,271		(74	)		54,197
Assets held for sale		69,699		4,127			73,826
Operating lease right-of-use assets		—		13,019			13,019
Liabilities held for sale		13,062		4,136			17,198
Deferred tax liabilities		1,177		114			1,291
Non-current lease liabilities		—		12,561			12,561
Accumulated earnings		363,965		261			364,226

Purchase price, cash consideration, net of cash acquired	$	14,823
Purchase price, fair value of contingent consideration		653
Total purchase price, net of cash acquired		15,476
Accounts receivable	$	883
Inventory		1,698
Prepaid expenses and other assets		241
Operating lease right-of-use assets		263
Property and equipment		260
Other intangible assets		4,380
Goodwill		9,816
Assumed liabilities		(2,065	)
Net assets acquired	$	15,476

Cash	$	1,422
Accounts receivable, net		2,238
Inventory, net		4,936
Prepaid expenses and other assets		215
Operating lease right-of-use assets		3,926
Investment		—
Property and equipment, net		7,356
Other intangible assets, net		1,033
Deferred income tax assets		4,371
Impairment loss		(18,910	)
Total assets held for sale	$	6,587
Accounts payable		420
Accrued liabilities		2,238
Operating lease liabilities		3,929
Total liabilities held for sale	$	6,587

Nine Months Ended September 30, 2019
Balance, beginning of period	$	1,597
Additions to unearned revenue		549
Reclassified to revenue		(1,211	)
Reclassified to held for sale		(168	)
Currency impacts		(20	)
Balance, end of period	$	747

	Defined Benefit Pension Plans			Foreign Currency Translation Adjustments			Commodity Hedge Derivatives				Foreign Currency Hedge Derivatives				Total
Balance at December 31, 2017	$	(2,366	)	$	(17,555	)	$	277			$	(800	)		$	(20,444	)
Cumulative effect of accounting change due to adoption of ASU 2018-02		(40	)		—			—				—				(40	)
Other comprehensive income (loss) before reclassifications		—			(14,519	)		—				2,048				(12,471	)
Income tax effect of other comprehensive income (loss) before reclassifications		—			(217	)		—				(615	)			(832	)
Amounts reclassified from accumulated other comprehensive income (loss) into net income (loss)		—			—			(218	)	a		256		a		38
Income taxes reclassified into net income (loss)		—			—			(59	)			(69	)			(128	)
Net current period other comprehensive income (loss)		(40	)		(14,736	)		(277	)			1,620				(13,433	)
Balance at September 30, 2018	$	(2,406	)	$	(32,291	)	$	—			$	820			$	(33,877	)

Supplemental Cash Flow Information:
Gain on sale and leaseback transactions, net	$	207
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	4,539
Right-of-use lease assets obtained in exchange for lease obligations:
Operating leases	$	3,339

2019 (excluding the nine months ended September 30, 2019)	$	1,393
2020		4,570
2021		2,674
2022		1,550
2023		790
2024 or later		2,600
Total future minimum lease payments	$	13,577
Less imputed interest		(1,703	)
Total	$	11,874

	(In thousands)
Working capital at December 31, 2018	$	267,679
Increase in cash, cash equivalents and restricted cash		6,340
Impairment loss on assets classified as held for sale		(21,206	)
Foreign currency effect on working capital		(5,044	)
Increase in accounts receivable		6,454
Decrease in tax receivables		(9,137	)
Increase in inventory		6,376
Decrease in prepaid expenses and other assets		(3,110	)
Decrease in accounts payable		2,591
Increase in accrued liabilities		(5,780	)
Decrease in working capital due to the sale of a business		(42,530	)
Increase in net current assets classified as held for sale		6,505
Increase in working capital from acquisition of new company		5,203
Working capital at September 30, 2019	$	214,341

Period	(a) Total Number of Shares Purchased (1)		(b) Average Price Paid per Share		(c) Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs		(d) Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (2)
July 1, 2019 to July 31, 2019		213,565	$	40.20		213,565		104,974,519
August 1, 2019 to August 31, 2019		225,398	$	37.77		225,398		96,463,515
September 1, 2019 to September 30, 2019		195,662	$	40.50		195,662		88,559,879